@article{muthusamy_williams_o'toole_brudvig_adler_weimer_muddiman_ghashghaei_2022, title={Phosphorylation-dependent proteome of Marcks in ependyma during aging and behavioral homeostasis in the mouse forebrain}, volume={1}, ISSN={["2509-2723"]}, url={http://dx.doi.org/10.1007/s11357-022-00517-3}, DOI={10.1007/s11357-022-00517-3}, abstractNote={Ependymal cells (ECs) line the ventricular surfaces of the mammalian central nervous system (CNS) and their development is indispensable to structural integrity and functions of the CNS. We previously reported that EC-specific genetic deletion of the myristoylated alanine-rich protein kinase C substrate (Marcks) disrupts barrier functions and elevates oxidative stress and lipid droplet accumulation in ECs causing precocious cellular aging. However, little is known regarding the mechanisms that mediate these changes in ECs. To gain insight into Marcks-mediated mechanisms, we performed mass spectrometric analyses on Marcks-associated proteins in young and aged ECs in the mouse forebrain using an integrated approach. Network analysis on annotated proteins revealed that the identified Marcks-associated complexes are in part involved in protein transport mechanisms in young ECs. In fact, we found perturbed intracellular vesicular trafficking in cultured ECs with selective deletion of Marcks (Marcks-cKO mice), or upon pharmacological alteration to phosphorylation status of Marcks. In comparison, Marcks-associated protein complexes in aged ECs appear to be involved in regulation of lipid metabolism and responses to oxidative stress. Confirming this, we found elevated signatures of inflammation in the cerebral cortices and the hippocampi of young Marcks-cKO mice. Interestingly, behavioral testing using a water maze task indicated that spatial learning and memory is diminished in young Marcks-cKO mice similar to aged wildtype mice. Taken together, our study provides first line of evidence for potential mechanisms that may mediate differential Marcks functions in young and old ECs, and their effect on forebrain homeostasis during aging.}, number={4}, journal={GEROSCIENCE}, publisher={Springer Science and Business Media LLC}, author={Muthusamy, Nagendran and Williams, Taufika I and O'Toole, Ryan and Brudvig, Jon J. and Adler, Kenneth B. and Weimer, Jill M. and Muddiman, David C. and Ghashghaei, H. Troy}, year={2022}, month={Jan} } @article{dinh_paudel_brochu_popowski_gracieux_cores_huang_hensley_harrell_vandergriff_et al._2020, title={Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis}, volume={11}, ISSN={["2041-1723"]}, url={http://dx.doi.org/10.1038/s41467-020-14344-7}, DOI={10.1038/s41467-020-14344-7}, abstractNote={Abstract Idiopathic pulmonary fibrosis (IPF) is a fatal and incurable form of interstitial lung disease in which persistent injury results in scar tissue formation. As fibrosis thickens, the lung tissue loses the ability to facilitate gas exchange and provide cells with needed oxygen. Currently, IPF has few treatment options and no effective therapies, aside from lung transplant. Here we present a series of studies utilizing lung spheroid cell-secretome (LSC-Sec) and exosomes (LSC-Exo) by inhalation to treat different models of lung injury and fibrosis. Analysis reveals that LSC-Sec and LSC-Exo treatments could attenuate and resolve bleomycin- and silica-induced fibrosis by reestablishing normal alveolar structure and decreasing both collagen accumulation and myofibroblast proliferation. Additionally, LSC-Sec and LSC-Exo exhibit superior therapeutic benefits than their counterparts derived from mesenchymal stem cells in some measures. We showed that an inhalation treatment of secretome and exosome exhibited therapeutic potential for lung regeneration in two experimental models of pulmonary fibrosis.}, number={1}, journal={NATURE COMMUNICATIONS}, publisher={Springer Science and Business Media LLC}, author={Dinh, Phuong-Uyen C. and Paudel, Dipti and Brochu, Hayden and Popowski, Kristen D. and Gracieux, M. Cyndell and Cores, Jhon and Huang, Ke and Hensley, M. Taylor and Harrell, Erin and Vandergriff, Adam C. and et al.}, year={2020}, month={Feb} } @misc{sheats_yin_fang_park_crews_parikh_dickson_adler_2019, title={MARCKS and Lung Disease}, volume={60}, ISSN={["1535-4989"]}, DOI={10.1165/rcmb.2018-0285TR}, abstractNote={Section:ChooseTop of pageAbstract <50 million LSC cells at Passage 2. These cells were characterized by flow cytometry and immunohistochemistry and were shown to represent a mixture of lung stem cells and supporting cells. When introduced systemically into nude mice, LSCs were retained primarily in the lungs for up to 21 days.Here, for the first time, we demonstrated that direct culture and expansion of human lung progenitor cells from pulmonary tissues, acquired through a minimally invasive biopsy, is possible and straightforward with a three-dimensional culture technique. These cells could be utilized in long-term expansion of lung progenitor cells and as part of the development of cell-based therapies for the treatment of lung diseases such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF).}, number={1}, journal={Respiratory Research}, publisher={Springer Nature}, author={Dinh, Phuong-Uyen C. and Cores, Jhon and Hensley, M. Taylor and Vandergriff, Adam C. and Tang, Junnan and Allen, Tyler A. and Caranasos, Thomas G. and Adler, Kenneth B. and Lobo, Leonard J. and Cheng, Ke}, year={2017}, month={Jun} } @article{yin_fang_park_crews_parikh_adler_2016, title={An Inhaled Inhibitor of Myristoylated Alanine-Rich C Kinase Substrate Reverses LPS-Induced Acute Lung Injury in Mice}, volume={55}, ISSN={["1535-4989"]}, DOI={10.1165/rcmb.2016-0236rc}, abstractNote={Intratracheal instillation of bacterial LPS is a well-established model of acute lung injury (ALI) and/or acute respiratory distress syndrome (ARDS). Because the myristoylated alanine-rich C kinase substrate (MARCKS) protein is involved in neutrophil migration and proinflammatory cytokine production, we examined whether an aerosolized peptide that inhibits MARCKS function could attenuate LPS-induced lung injury in mice. The peptide, BIO-11006, was delivered at 50 μM via inhalation either just before intratracheal instillation of 5 μg of LPS into Balb/C mice, or 4, 12, 24, or 36 hours after LPS instillation. Effects of BIO-11006 were evaluated via analysis of mouse disease-related behavior, lung histology, bronchoalveolar lavage fluid total protein, neutrophil counts and percentages, cytokine (KC [CXCl1, mouse IL-8 equivalent] and TNF-α) expression, and activation of NF-κB in lung tissue. Treatment with aerosolized BIO-11006 at 0, 4, 12, 24, and even 36 hours after LPS instillation reversed the disease process: mouse behavior returned to normal after two treatments 12 hours apart with the inhaled peptide after LPS injury, whereas control LPS-instilled animals treated with PBS only remained moribund. Histological appearance of inflammation, bronchoalveolar lavage fluid protein levels, leukocyte and neutrophil numbers, KC and TNF-α gene and protein expression, and NF-κB activation were all significantly attenuated by inhaled BIO-11006 at all time points. These results implicate MARCKS protein in the pathogenesis of ALI/ARDS and suggest that MARCKS-inhibitory peptide(s), delivered by inhalation, could represent a new and potent therapeutic treatment for ALI/ARDS, even if administered well after the disease process has begun.}, number={5}, journal={AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY}, author={Yin, Qi and Fang, Shijing and Park, Joungjoa and Crews, Anne L. and Parikh, Indu and Adler, Kenneth B.}, year={2016}, month={Nov}, pages={617–622} } @article{muthusamy_sommerville_moeser_stumpo_sannes_adler_blackshear_weimer_ghashghaei_2015, title={MARCKS-dependent mucin clearance and lipid metabolism in ependymal cells are required for maintenance of forebrain homeostasis during aging}, volume={14}, ISSN={["1474-9726"]}, DOI={10.1111/acel.12354}, abstractNote={Summary Ependymal cells ( EC s) form a barrier responsible for selective movement of fluids and molecules between the cerebrospinal fluid and the central nervous system. Here, we demonstrate that metabolic and barrier functions in EC s decline significantly during aging in mice. The longevity of these functions in part requires the expression of the myristoylated alanine‐rich protein kinase C substrate ( MARCKS ). Both the expression levels and subcellular localization of MARCKS in EC s are markedly transformed during aging. Conditional deletion of MARCKS in EC s induces intracellular accumulation of mucins, elevated oxidative stress, and lipid droplet buildup. These alterations are concomitant with precocious disruption of ependymal barrier function, which results in the elevation of reactive astrocytes, microglia, and macrophages in the interstitial brain tissue of young mutant mice. Interestingly, similar alterations are observed during normal aging in EC s and the forebrain interstitium. Our findings constitute a conceptually new paradigm in the potential role of EC s in the initiation of various conditions and diseases in the aging brain.}, number={5}, journal={AGING CELL}, author={Muthusamy, Nagendran and Sommerville, Laura J. and Moeser, Adam J. and Stumpo, Deborah J. and Sannes, Philip and Adler, Kenneth and Blackshear, Perry J. and Weimer, Jill M. and Ghashghaei, H. Troy}, year={2015}, month={Oct}, pages={764–773} } @misc{chen_chiu_adler_wu_2014, title={A Novel Predictor of Cancer Malignancy: Up-regulation of Myristoylated Alanine-Rich C Kinase Substrate Phosphorylation in Lung Cancer}, volume={189}, ISSN={["1535-4970"]}, DOI={10.1164/rccm.201401-0053le}, abstractNote={To the Editor: Lung cancer currently remains the leading cause of cancer-related deaths because of its aggressive nature. The 5-year survival rates for localized and regional disease are 54 and 26%, respectively, but only 4% for patients with late-stage (stage IV) disease (1). Thus, development of biomarkers to identify patients at high risk for aggressive progression is of urgent need. Recently, we have reported myristoylated alanine-rich C kinase substrate (MARCKS), predominantly its phosphorylated state, as a risk factor associated with lung cancer invasiveness and metastasis (2). MARCKS is a substrate of protein kinase C, and also a membrane-associated protein. Upon phosphorylation at Ser159 and Ser163 within its phosphorylation site domain, phosphorylated MARCKS (phospho-MARCKS) is detached from the plasma membrane and is able to regulate various cellular processes, including cell migration and exocytic vesicle release (2–4). In the lungs, MARCKS has been extensively studied because of its role in regulating mucus secretion and inflammation. Inhibition of MARCKS activity not only reduces airway mucus hypersecretion both in vitro and in vivo (3, 5), but also represses inflammatory leukocyte migration and degranulation (6, 7). There have been limited studies on MARCKS in cancer metastasis, but the results have been conflicting (8–13). This is because MARCKS expression is ubiquitous in various normal and tumor tissues. Despite this, there is a consensus that phospho-MARCKS, a post-translational modification, is associated with cell motility, and has a role in the regulation of cancer cell invasiveness and metastasis (2, 4, 14, 15). Of note, our laboratory discovered that inhibition of MARCKS phosphorylation was able to reduce lung cancer metastasis in murine models (2). However, the clinical significance of phospho-MARCKS in different cancers remains to be determined. In particular, there is limited information regarding its relevance in cancer progression, especially lung cancer. Based on 18 pairs of normal and malignant lung cancer tissue sections, we previously reported that elevated phospho-MARCKS was seen in malignant lung cancer tissue sections, but not in their adjacent normal counterparts (2), suggesting a potential association between MARCKS phosphorylation and more aggressive lung cancer histological grades. To investigate more fully this previous finding, we analyzed samples from a cohort of 110 human patients with lung cancer using immunohistochemical staining with an anti-pSer159/163 MARCKS monoclonal antibody (see the online supplement). The clinical characteristics of these patients are summarized in Table 1. Consistent with our previous reports (2), high levels of MARCKS phosphorylation were found in tumor tissues compared with normal lung tissues (Figures 1A–1F). Weak phospho-MARCKS staining was observed in the cytoplasm of lung cancer tissue samples from patients in stage I (Figure 1C). In contrast, strong MARCKS phosphorylation occurred in advanced-stage lung cancer tissue samples (Figures 1D–1F). The levels of MARCKS phosphorylation correlated significantly with advanced stages of disease (Figure 1G, Pearson’s chi-square test). Table 1: Phosphorylated Myristoylated Alanine-Rich C Kinase Substrate Levels in Relation to Clinicopathologic Characteristics of Patients with Non–Small Cell Lung Cancer* Figure 1. High phosphorylated myristoylated alanine-rich C kinase substrate (phospho-MARCKS) levels correlate with advanced stages, lymph node metastasis, and invasion of lung cancer. (A–F) Representative images of immunohistochemical staining using anti-pSer159/163 ... To quantitatively investigate these impressions, bivariate logistic regression models to predict the likelihood of high phospho-MARCKS levels from advanced tumor stages were estimated, and the probabilities of high phospho-MARCKS with stage I to III are shown in Figure 1H. The analyses demonstrated that, for a one-unit increase in stages II and III, the log odds of high expression of phospho-MARCKS levels increased by 1.00 and 2.46 compared with stage I. There were significant differences in the logistic probabilities of high phospho-MARCKS levels between stages I and II (P = 0.039), as well as stages I and III (P < 0.001), respectively. These results suggest that phospho-MARCKS may be a promising clinical predictor of tumor stages in patients with lung cancer. Moreover, we also investigated the significance of phospho-MARCKS in lymph node status and found that higher levels of MARCKS phosphorylation correlated with lymph node metastasis (Figure 1I, N0 versus N1–2). Notably, MARCKS phosphorylation was lower in a subtype of adenocarcinoma, bronchoalveolar carcinoma, which shows a less invasive phenotype than adenocarcinoma (Figure 1J, AC versus bronchoalveolar carcinoma). Because tumor necrosis is a common event in aggressive cancers, we further checked phospho-MARCKS levels in the 10 tumor tissues with necrosis in this set of tissue arrays. Interestingly, we found higher staining intensity and increased numbers of cells stained with anti–phospho-MARCKS antibody in these tumors. These data raise the possibility that high phospho-MARCKS levels may contribute to cancer progression in non–small cell lung cancers, and the detection of phospho-MARCKS could potentially be used as a prognostic biomarker for the disease. In this correspondence, we demonstrate that higher MARCKS phosphorylation is correlated with lung cancer in advanced stages (stage II–IV), lymph node metastatic status, and malignant phenotypes. In addition to our previously published results (2), the current work further confirms the importance of phospho-MARCKS in driving the progression of lung cancer toward more malignancy, suggesting that phospho-MARCKS levels may determine the progression of localized lung cancer toward late stage. Taken together, high phospho-MARCKS levels appear to confer cancer malignancy, and may serve as a novel biomarker. Inhibition of MARCKS phosphorylation, the post-translational step, may be an effective strategy for controlling lung cancer progression.}, number={8}, journal={AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE}, author={Chen, Ching-Hsien and Chiu, Chun-Lung and Adler, Kenneth B. and Wu, Reen}, year={2014}, month={Apr}, pages={1002–1004} } @article{chen_thai_yoneda_adler_yang_wu_2014, title={A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis}, volume={33}, DOI={10.1038/onc.2013.336}, abstractNote={Myristoylated Alanine-Rich C Kinase Substrate (MARCKS), a substrate of protein kinase C, is a key regulatory molecule controlling mucus granule secretion by airway epithelial cells as well as directed migration of leukocytes, stem cells and fibroblasts. Phosphorylation of MARKCS may be involved in these responses. However, the functionality of MARCKS and its related phosphorylation in lung cancer malignancy have not been characterized. This study demonstrated elevated levels of MARCKS and phospho-MARCKS in highly invasive lung cancer cell lines and lung cancer specimens from non-small-cell lung cancer patients. siRNA knockdown of MARCKS expression in these highly invasive lung cancer cell lines reduced cell migration and suppressed PI3K (phosphatidylinositol 3'-kinase)/Akt phosphorylation and Slug level. Interestingly, treatment with a peptide identical to the MARCKS N-terminus sequence (the MANS peptide) impaired cell migration in vitro and also the metastatic potential of invasive lung cancer cells in vivo. Mechanistically, MANS peptide treatment resulted in a coordination of increase of E-cadherin expression, suppression of MARCKS phosphorylation and AKT/Slug signalling pathway but not the expression of total MARCKS. These results indicate a crucial role for MARCKS, specifically its phosphorylated form, in potentiating lung cancer cell migration/metastasis and suggest a potential use of MARCKS-related peptides in the treatment of lung cancer metastasis.}, number={28}, journal={Oncogene}, author={Chen, C. H. and Thai, P. and Yoneda, K. and Adler, K. B. and Yang, P. C. and Wu, R.}, year={2014}, pages={3696–3706} } @article{parikh_long_yin_fang_adler_2014, title={Aerosolized MANS and BIO-11006 Peptides Inhibit Lung Cancer Metastasis in SCID Mice}, volume={90}, ISSN={0360-3016}, url={http://dx.doi.org/10.1016/J.IJROBP.2014.08.247}, DOI={10.1016/J.IJROBP.2014.08.247}, abstractNote={Purpose/Objective(s)MARCKS, a ubiquitous 332-aa protein with a highly conserved N-terminal sequence, plays a key role in cell migration. MARCKS elevations in cancer are associated with metastasis and worse outcomes; Chen et al found high phospho MARCKS levels in human NSCLC tissues and showed that MANS, a 24-aa N-terminal MARCKS fragment that inhibits MARCKS function, prevents metastasis of PC9 cells orthotopically injected into the left lung of SCID mice by q3d ip injections. In this study we compared anti-metastatic effects of aerosolized inhaled MANS and its much shorter analog, BIO-11006, in NSCLC in vivo.Materials/MethodsForty SCID mice (n=8 per group) were inoculated with 2.5 x 106 A549 cells by tail vein injection, and treated with aerosolized (Aerogen preclinical nebulizer) MANS, BIO-11006 peptide, or PBS qod for 7 weeks. For each treatment, MANS and BIO-11006 peptide (100 μM), dissolved in five mL PBS, were nebulized over 30 min. The treatment, given every other day, was started either at Day -1, or at Day +3. On Day 53, animals were sacrificed and necropsied. Lungs were harvested, weighed, perfused with 15% India ink, washed with Fekete’s solution, photographed, and metastatic tumor nodules counted and recorded. Other organs were also harvested from control and treated groups and examined for metastasis.ResultsBoth aerosolized MANS and BIO-11006 significantly reduced lung metastasis compared to vehicle control. After the seven week treatment period, the vehicle control exhibited 97±21 metastatic nodules while BIO-11006 (-1 day and +3 day) groups had 34±14* and 21±6**, respectively. Similarly, MANS (-1 day and +3 day) groups showed 22±7* and 13±4** metastatic nodules, respectively. [*=P<.05 and **=P<.01 compared to vehicle; 1-way ANOVA/Bonferroni's Multiple Comparison Test]. Reductions in metastasis caused by MANS and BIO-11006 were not different if aerosol treatment was started before versus after A549 cell injections, and were not different from each other. Two animals exhibited metastasis beyond the lungs; both were in vehicle control group.ConclusionsBoth MARCKS inhibitory peptides, MANS and BIO-11006 significantly inhibit metastasis of A549 cells in SCID mice when administered by aerosol whether treatment is initiated before or after tail vein injection of human A549 lung cancer cells. Purpose/Objective(s)MARCKS, a ubiquitous 332-aa protein with a highly conserved N-terminal sequence, plays a key role in cell migration. MARCKS elevations in cancer are associated with metastasis and worse outcomes; Chen et al found high phospho MARCKS levels in human NSCLC tissues and showed that MANS, a 24-aa N-terminal MARCKS fragment that inhibits MARCKS function, prevents metastasis of PC9 cells orthotopically injected into the left lung of SCID mice by q3d ip injections. In this study we compared anti-metastatic effects of aerosolized inhaled MANS and its much shorter analog, BIO-11006, in NSCLC in vivo. MARCKS, a ubiquitous 332-aa protein with a highly conserved N-terminal sequence, plays a key role in cell migration. MARCKS elevations in cancer are associated with metastasis and worse outcomes; Chen et al found high phospho MARCKS levels in human NSCLC tissues and showed that MANS, a 24-aa N-terminal MARCKS fragment that inhibits MARCKS function, prevents metastasis of PC9 cells orthotopically injected into the left lung of SCID mice by q3d ip injections. In this study we compared anti-metastatic effects of aerosolized inhaled MANS and its much shorter analog, BIO-11006, in NSCLC in vivo. Materials/MethodsForty SCID mice (n=8 per group) were inoculated with 2.5 x 106 A549 cells by tail vein injection, and treated with aerosolized (Aerogen preclinical nebulizer) MANS, BIO-11006 peptide, or PBS qod for 7 weeks. For each treatment, MANS and BIO-11006 peptide (100 μM), dissolved in five mL PBS, were nebulized over 30 min. The treatment, given every other day, was started either at Day -1, or at Day +3. On Day 53, animals were sacrificed and necropsied. Lungs were harvested, weighed, perfused with 15% India ink, washed with Fekete’s solution, photographed, and metastatic tumor nodules counted and recorded. Other organs were also harvested from control and treated groups and examined for metastasis. Forty SCID mice (n=8 per group) were inoculated with 2.5 x 106 A549 cells by tail vein injection, and treated with aerosolized (Aerogen preclinical nebulizer) MANS, BIO-11006 peptide, or PBS qod for 7 weeks. For each treatment, MANS and BIO-11006 peptide (100 μM), dissolved in five mL PBS, were nebulized over 30 min. The treatment, given every other day, was started either at Day -1, or at Day +3. On Day 53, animals were sacrificed and necropsied. Lungs were harvested, weighed, perfused with 15% India ink, washed with Fekete’s solution, photographed, and metastatic tumor nodules counted and recorded. Other organs were also harvested from control and treated groups and examined for metastasis. ResultsBoth aerosolized MANS and BIO-11006 significantly reduced lung metastasis compared to vehicle control. After the seven week treatment period, the vehicle control exhibited 97±21 metastatic nodules while BIO-11006 (-1 day and +3 day) groups had 34±14* and 21±6**, respectively. Similarly, MANS (-1 day and +3 day) groups showed 22±7* and 13±4** metastatic nodules, respectively. [*=P<.05 and **=P<.01 compared to vehicle; 1-way ANOVA/Bonferroni's Multiple Comparison Test]. Reductions in metastasis caused by MANS and BIO-11006 were not different if aerosol treatment was started before versus after A549 cell injections, and were not different from each other. Two animals exhibited metastasis beyond the lungs; both were in vehicle control group. Both aerosolized MANS and BIO-11006 significantly reduced lung metastasis compared to vehicle control. After the seven week treatment period, the vehicle control exhibited 97±21 metastatic nodules while BIO-11006 (-1 day and +3 day) groups had 34±14* and 21±6**, respectively. Similarly, MANS (-1 day and +3 day) groups showed 22±7* and 13±4** metastatic nodules, respectively. [*=P<.05 and **=P<.01 compared to vehicle; 1-way ANOVA/Bonferroni's Multiple Comparison Test]. Reductions in metastasis caused by MANS and BIO-11006 were not different if aerosol treatment was started before versus after A549 cell injections, and were not different from each other. Two animals exhibited metastasis beyond the lungs; both were in vehicle control group. ConclusionsBoth MARCKS inhibitory peptides, MANS and BIO-11006 significantly inhibit metastasis of A549 cells in SCID mice when administered by aerosol whether treatment is initiated before or after tail vein injection of human A549 lung cancer cells. Both MARCKS inhibitory peptides, MANS and BIO-11006 significantly inhibit metastasis of A549 cells in SCID mice when administered by aerosol whether treatment is initiated before or after tail vein injection of human A549 lung cancer cells.}, number={5}, journal={International Journal of Radiation Oncology*Biology*Physics}, publisher={Elsevier BV}, author={Parikh, I. and Long, W.A. and Yin, Q. and Fang, S. and Adler, K.B.}, year={2014}, month={Nov}, pages={S51} } @article{sheats_sung_adler_jones_inflammation_2014, title={In Vitro Neutrophil Migration Requires Protein Kinase C-Delta (δ-PKC)-Mediated Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Phosphorylation}, volume={38}, ISSN={0360-3997 1573-2576}, url={http://dx.doi.org/10.1007/S10753-014-0078-9}, DOI={10.1007/S10753-014-0078-9}, abstractNote={Dysregulated release of neutrophil reactive oxygen species and proteolytic enzymes contributes to both acute and chronic inflammatory diseases. Therefore, molecular regulators of these processes are potential targets for new anti-inflammatory therapies. We have shown previously that myristoylated alanine-rich C-kinase substrate (MARCKS), a well-known actin binding protein and protein kinase C (PKC) substrate, is a key regulator of neutrophil functions. In the current study, we investigate the role of PKC-mediated MARCKS phosphorylation in neutrophil migration and adhesion in vitro. We report that treatment of human neutrophils with the δ-PKC inhibitor rottlerin significantly attenuates f-Met-Leu-Phe (fMLF)-induced MARCKS phosphorylation (IC50 = 5.709 μM), adhesion (IC50 = 8.4 μM), and migration (IC50 = 6.7 μM), while α-, β-, and ζ-PKC inhibitors had no significant effect. We conclude that δ-PKC-mediated MARCKS phosphorylation is essential for human neutrophil migration and adhesion in vitro. These results implicate δ-PKC-mediated MARCKS phosphorylation as a key step in the inflammatory response of neutrophils.}, number={3}, journal={Inflammation}, publisher={Springer Science and Business Media LLC}, author={Sheats, M.K. and Sung, E.J. and Adler, K.B. and Jones, S.L. and Inflammation}, year={2014}, month={Dec}, pages={1126–1141} } @article{sheats_pescosolido_hefner_sung_adler_jones_2014, title={Myristoylated Alanine Rich C Kinase Substrate (MARCKS) is essential to β2-integrin dependent responses of equine neutrophils}, volume={160}, ISSN={0165-2427}, url={http://dx.doi.org/10.1016/j.vetimm.2014.04.009}, DOI={10.1016/j.vetimm.2014.04.009}, abstractNote={Neutrophil infiltration is a prominent feature in a number of pathologic conditions affecting horses including recurrent airway obstruction, ischemia-reperfusion injury, and laminitis. Cell signaling components involved in neutrophil migration represent targets for novel anti-inflammatory therapies. In order to migrate into tissue, neutrophils must respond to chemoattractant signals in their external environment through activation of adhesion receptors (i.e. integrins) and reorganization of the actin cytoskeleton. Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS), a highly conserved actin-binding protein, has a well demonstrated role in cytoskeletal dependent cellular functions (i.e. adhesion, spreading, and migration), but the details of MARCKS involvement in these processes remain vague. We hypothesized that MARCKS serves as a link between the actin cytoskeleton and integrin function in neutrophils. Using a MARCKS-specific inhibitor peptide known as MANS on equine neutrophils in vitro, we demonstrate that inhibition of MARCKS function significantly attenuates β2-integrin-dependent neutrophil functions including migration, adhesion, and immune complex-mediated respiratory burst. The MANS peptide did not, however, inhibit the β2-integrin-independent PMA mediated respiratory burst. These results attest to the essential role of MARCKS function in regulating neutrophil responses, and strongly implicate MARCKS as a potential regulator of β2-integrins in neutrophils.}, number={3-4}, journal={Veterinary Immunology and Immunopathology}, publisher={Elsevier BV}, author={Sheats, Mary K. and Pescosolido, Kimberly C. and Hefner, Ethan M. and Sung, Eui Jae and Adler, Kenneth B. and Jones, Samuel L.}, year={2014}, month={Aug}, pages={167–176} } @article{chen_statt_chiu_thai_arif_adler_wu_2014, title={Targeting Myristoylated Alanine-Rich C Kinase Substrate Phosphorylation Site Domain in Lung Cancer Mechanisms and Therapeutic Implications}, volume={190}, ISSN={["1535-4970"]}, DOI={10.1164/rccm.201408-1505oc}, abstractNote={Phosphorylation of myristoylated alanine-rich C kinase substrate (phospho-MARCKS) at the phosphorylation site domain (PSD) is crucial for mucus granule secretion and cell motility, but little is known concerning its function in lung cancer.We aimed to determine if MARCKS PSD activity can serve as a therapeutic target and to elucidate the molecular basis of this potential.The clinical relevance of phospho-MARCKS was first confirmed. Next, we used genetic approaches to verify the functionality and molecular mechanism of phospho-MARCKS. Finally, cancer cells were pharmacologically inhibited for MARCKS activity and subjected to functional bioassays.We demonstrated that higher phospho-MARCKS levels were correlated with shorter overall survival of lung cancer patients. Using shRNA silencing and ectopic expression of wild-type and PSD-mutated (S159/163A) MARCKS, we showed that elevated phospho-MARCKS promoted cancer growth and erlotinib resistance. Further studies demonstrated an interaction of phosphoinositide 3-kinase with MARCKS, but not with phospho-MARCKS. Interestingly, phospho-MARCKS acted in parallel with increased phosphatidylinositol (3,4,5)-triphosphate pools and AKT activation in cells. Through treatment with a 25-mer peptide targeting the MARCKS PSD motif (MPS peptide), we were able to suppress tumor growth and metastasis in vivo, and reduced levels of phospho-MARCKS, phosphatidylinositol (3,4,5)-triphosphate, and AKT activity. This peptide also enhanced the sensitivity of lung cancer cells to erlotinib treatment, especially those with sustained activation of phosphoinositide 3-kinase/AKT signaling.These results suggest a key role for MARCKS PSD in cancer disease and provide a unique strategy for inhibiting the activity of MARCKS PSD as a treatment for lung cancer.}, number={10}, journal={AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE}, author={Chen, Ching-Hsien and Statt, Sarah and Chiu, Chun-Lung and Thai, Philip and Arif, Muhammad and Adler, Kenneth B. and Wu, Reen}, year={2014}, month={Nov}, pages={1127–1138} } @article{adler_shapiro_holtzman_mcdonald_2014, title={The Red Journal at 25 Years Looking Back and Looking Ahead}, volume={50}, ISSN={["1535-4989"]}, DOI={10.1165/rcmb.2014-0104ed}, number={5}, journal={AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY}, author={Adler, Kenneth B. and Shapiro, Steven D. and Holtzman, Michael J. and McDonald, John A.}, year={2014}, month={May}, pages={839–840} } @article{li_d’annibale-tolhurst_adler_fang_yin_birkenheuer_levy_jones_sung_hawkins_et al._2013, title={A Myristoylated Alanine-Rich C Kinase Substrate–Related Peptide Suppresses Cytokine mRNA and Protein Expression in LPS-Activated Canine Neutrophils}, volume={48}, ISSN={1044-1549 1535-4989}, url={http://dx.doi.org/10.1165/rcmb.2012-0278OC}, DOI={10.1165/rcmb.2012-0278oc}, abstractNote={Section:ChooseTop of pageAbstract <90%. We studied the effect of intranasal pretreatment with this peptide on specific airway conductance (sGaw) during challenge with MCh in mice with allergen-induced mucous cell metaplasia. sGaw was noninvasively measured in spontaneously breathing restrained mice, using a double-chamber plethysmograph. Pretreatment with MANS peptide, but not a control peptide [random NH(2)-terminal sequence (RNS)], resulted in partial inhibition of the fall in sGaw induced by 60 mM MCh (mean +/- SE; baseline 1.15 +/- 0.06; MANS/MCh 0.82 +/- 0.05; RNS/MCh 0.55 +/- 0.05 cmH(2)O/s). The protective effect of MANS was also seen in mice challenged with allergen for 3 consecutive days to increase airway hyperresponsiveness, although the degree of protection was less (baseline 1.1 +/- 0.08; MANS/MCh, 0.65 +/- 0.06; RNS/MCh 0.47 +/- 0.03 cmH(2)O/s). Because routine sGaw measurement in mice includes nasal airways, the effectiveness of MANS was also confirmed in mice breathing through their mouths after nasal occlusion (baseline 0.92 +/- 0.05; MANS/MCh 0.83 +/- 0.06; RNS/MCh 0.61 +/- 0.03 cmH(2)O/s). In all instances, sGaw in the MANS-pretreated group was approximately 35% higher than in RNS-treated controls, and mucous obstruction accounted for approximately 50% of the MCh-induced fall in sGaw. In summary, mucin secretion has a significant role in airway obstruction in a mouse model of allergic asthma, and strategies to inhibit mucin secretion merit further investigation.}, number={1}, journal={JOURNAL OF APPLIED PHYSIOLOGY}, author={Agrawal, A. and Rengarajan, S. and Adler, K. B. and Ram, A. and Ghosh, B. and Fahim, M. and Dickey, B. F.}, year={2007}, month={Jan}, pages={399–405} } @misc{li_martin_adler_2007, title={Method and compositions for altering mucus secretion}, volume={7,265,088}, number={2007 Sept. 4}, publisher={Washington, DC: U.S. Patent and Trademark Office}, author={Li, Y.-H. and Martin, L. D. and Adler, K. B.}, year={2007} } @article{kraft_nijira lugogo_adler_crews_moss_stalls_church_slade_beaver_chu_2007, title={Mycoplasma pneumoniae increases airway epithelial cell MUC5AC expression in asthma.}, volume={175}, journal={404nOtfound}, author={Kraft, M. and Nijira Lugogo, H. W. and Adler, K. B. and Crews, A. L. and Moss, T. A. and Stalls, M. A. and Church, T. D. and Slade, D. J. and Beaver, D. M. and Chu, H. W.}, year={2007}, pages={A324} } @article{park_adler_2007, title={Potential therapy for mucus hypersecretion in COPD.}, volume={3}, DOI={10.1080/17471060601063231}, abstractNote={Mucus hypersecretion is a major pathophysiologic feature of chronic bronchitis. Although mucus functions as a barrier and a facilitator of mucociliary clearance, persistent mucus hypersecretion results in airway obstruction and compromised clearance of inhaled bacteria and particles from the airways of patients with chronic obstructive pulmonary disease. Treatment of mucus hypersecretion is a major therapeutic target; however, mechanisms of mucus hypersecretion remain unknown. Herein, we present evidence that human neutrophil elastase (HNE), a pathophysiologically relevant stimulant of mucus hypersecretion in the airways of patients with chronic bronchitis, provokes release of mucin (the glycoprotein component of mucus) by human airway epithelial cells in vitro. Signaling molecules involved in HNE-induced mucin hypersecretion include protein kinase C, specifically the delta isoform, and the myristoylated alanine-rich C kinase substrate protein. These molecules represent potential therapeutic targets for regulating mucin secretion in patients.}, journal={404nOtfound}, author={Park, J.-A. and Adler, K. B.}, year={2007}, pages={66–71} } @article{park_crews_lampe_fang_park_adler_2007, title={Protein kinase C delta regulates airway mucin secretion via phosphorylation of MARCKS protein}, volume={171}, ISSN={["1525-2191"]}, DOI={10.2353/ajpath.2007.070318}, abstractNote={Mucin hypersecretion is a major pathological feature of many respiratory diseases, yet cellular mechanisms regulating secretion of mucin have not been fully elucidated. Previously, we reported that mucin hypersecretion induced by human neutrophil elastase involves activation of protein kinase C (PKC), specifically the δ-isoform (PKCδ). Here, we further investigated the role of PKCδ in mucin hypersecretion using both primary human bronchial epithelial cells and the human bronchial epithelial 1 cell line as in vitro model systems. Phorbol-12-myristate-13-acetate (PMA)-induced mucin hypersecretion was significantly attenuated by rottlerin, a PKCδ-selective inhibitor. Rottlerin also reduced PMA- or human neutrophil elastase-induced phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) protein in these cells. Both secretion and MARCKS phosphorylation were significantly enhanced by the PKCδ activator bryostatin 1. A dominant-negative PKCδ construct (pEGFP-N1/PKCδK376R) transfected into human bronchial epithelial 1 cells significantly attenuated both PMA-induced mucin secretion and phosphorylation of MARCKS, whereas transfection of a wild-type construct increased PKCδ and enhanced mucin secretion and MARCKS phosphorylation. Similar transfections of a dominant-negative or wild-type PKCε construct did not affect either mucin secretion or MARCKS phosphorylation. The results suggest that PKCδ plays an important role in mucin secretion by airway epithelium via regulation of MARCKS phosphorylation. Mucin hypersecretion is a major pathological feature of many respiratory diseases, yet cellular mechanisms regulating secretion of mucin have not been fully elucidated. Previously, we reported that mucin hypersecretion induced by human neutrophil elastase involves activation of protein kinase C (PKC), specifically the δ-isoform (PKCδ). Here, we further investigated the role of PKCδ in mucin hypersecretion using both primary human bronchial epithelial cells and the human bronchial epithelial 1 cell line as in vitro model systems. Phorbol-12-myristate-13-acetate (PMA)-induced mucin hypersecretion was significantly attenuated by rottlerin, a PKCδ-selective inhibitor. Rottlerin also reduced PMA- or human neutrophil elastase-induced phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) protein in these cells. Both secretion and MARCKS phosphorylation were significantly enhanced by the PKCδ activator bryostatin 1. A dominant-negative PKCδ construct (pEGFP-N1/PKCδK376R) transfected into human bronchial epithelial 1 cells significantly attenuated both PMA-induced mucin secretion and phosphorylation of MARCKS, whereas transfection of a wild-type construct increased PKCδ and enhanced mucin secretion and MARCKS phosphorylation. Similar transfections of a dominant-negative or wild-type PKCε construct did not affect either mucin secretion or MARCKS phosphorylation. The results suggest that PKCδ plays an important role in mucin secretion by airway epithelium via regulation of MARCKS phosphorylation. Mucus produced by epithelium of respiratory, gastrointestinal, and reproductive tracts provides a barrier between the external environment and cellular components of the epithelial layer. Mucins, the glycoprotein component of mucus, constitute a family of large, highly glycosylated macromolecules that impart physical (aggregation, viscosity, viscoelasticity, and lubrication) and biological (protection) properties to mucus (reviewed in Ref. 1Rose MC Mucins: structure, function, and role in pulmonary diseases.Am J Physiol. 1992; 263: L413-L429PubMed Google Scholar). Airway mucus is an integral component of the mucociliary clearance system in the trachea and bronchi and thus serves to protect the lower airways and alveoli from impingement of particulate matter and pathogens. However, mucin secretion is abnormally augmented in disease states, such as chronic bronchitis, asthma, and cystic fibrosis, increasing morbidity and mortality in these patients (reviewed in Refs. 1Rose MC Mucins: structure, function, and role in pulmonary diseases.Am J Physiol. 1992; 263: L413-L429PubMed Google Scholar and 2Rogers DF Barnes PJ Treatment of airway mucus hypersecretion.Ann Med. 2006; 38: 116-125Crossref PubMed Scopus (172) Google Scholar). Mucin hypersecretion is potentiated by many pathophysiological mediators, such as bacterial proteinases and endotoxin, adenine and guanine nucleotides, cytokines, inflammatory mediators, and eicosanoids (reviewed in Ref. 3Adler KB Li Y Airway epithelium and mucus: intracellular signaling pathways for gene expression and secretion.Am J Respir Cell Mol Biol. 2001; 25: 397-400Crossref PubMed Scopus (50) Google Scholar). Intracellular mechanisms and signaling molecules involved in the secretory process have not been fully elucidated.Protein kinase C (PKC) is a serine/threonine kinase involved in various exocytotic events in different cell types, including secretion of mucin,4Abdullah LH Bundy JT Ehre C Davis CW Mucin secretion and PKC isoforms in SPOC1 goblet cells: differential activation by purinergic agonist and PMA.Am J Physiol Lung Cell Mol Physiol. 2003; 285: L149-L160PubMed Google Scholar, 5Plaisancie P Ducroc R El Homsi M Tsocas A Guilmeau S Zoghbi S Thibaudeau O Bado A Luminal leptin activates mucin-secreting goblet cells in the large bowel.Am J Physiol Gastrointest Liver Physiol. 2006; 290: G805-G812Crossref PubMed Scopus (59) Google Scholar insulin,6Yaney GC Fairbanks JM Deeney JT Korchak HM Tornheim K Corkey BE Potentiation of insulin secretion by phorbol esters is mediated by PKC-alpha and nPKC isoforms.Am J Physiol Endocrinol Metab. 2002; 283: E880-E888Crossref PubMed Scopus (34) Google Scholar neurotransmitters,7Shoji-Kasai Y Itakura M Kataoka M Yamamori S Takahashi M Protein kinase C-mediated translocation of secretory vesicles to plasma membrane and enhancement of neurotransmitter release from PC12 cells.Eur J Neurosci. 2002; 15: 1390-1394Crossref PubMed Scopus (50) Google Scholar and platelet dense granules.8Murugappan S Tuluc F Dorsam RT Shankar H Kunapuli SP Differential role of protein kinase C delta isoform in agonist-induced dense granule secretion in human platelets.J Biol Chem. 2004; 279: 2360-2367Crossref PubMed Scopus (92) Google Scholar Previously, we demonstrated that mucin secretion in airway epithelial cells is regulated by PKC via phosphorylation of the myristoylated alanine-rich C kinase substrate (MARCKS).9Li Y Martin LD Spizz G Adler KB MARCKS protein is a key molecule regulating mucin secretion by human airway epithelial cells in vitro.J Biol Chem. 2001; 276: 40982-40990Crossref PubMed Scopus (150) Google Scholar, 10Singer M Martin LD Vargaftig BB Park J Gruber AD Li Y Adler KB A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma.Nat Med. 2004; 10: 193-196Crossref PubMed Scopus (147) Google Scholar In addition, we demonstrated that mucin hypersecretion in human airway epithelial cells in vitro in response to human neutrophil elastase (HNE) appears to be mediated by the δ-isoform of PKC (PKCδ).11Park JA He F Martin LD Li Y Chorley BN Adler KB Human neutrophil elastase induces hypersecretion of mucin from well-differentiated human bronchial epithelial cells in vitro via a protein kinase C{delta}-mediated mechanism.Am J Pathol. 2005; 167: 651-661Abstract Full Text Full Text PDF PubMed Scopus (96) Google Scholar Not surprisingly, PKCδ, a novel PKC isoform, has a strong affinity for MARCKS and can phosphorylate MARCKS both in vitro and in vivo.12Fujise A Mizuno K Ueda Y Osada S Hirai S Takayanagi A Shimizu N Owada MK Nakajima H Ohno S Specificity of the high affinity interaction of protein kinase C with a physiological substrate, myristoylated alanine-rich protein kinase C substrate.J Biol Chem. 1994; 269: 31642-31648Abstract Full Text PDF PubMed Google Scholar, 13Herget T Oehrlein SA Pappin DJ Rozengurt E Parker PJ The myristoylated alanine-rich C-kinase substrate (MARCKS) is sequentially phosphorylated by conventional, novel and atypical isotypes of protein kinase C.Eur J Biochem. 1995; 233: 448-457Crossref PubMed Scopus (79) Google Scholar, 14Cabell CH Verghese GM Rankl NB Burns DJ Blackshear PJ MARCKS phosphorylation by individual protein kinase C isozymes in insect Sf9 cells.Proc Assoc Am Physicians. 1996; 108: 37-46PubMed Google Scholar Increasing evidence suggests that PKCδ mediates exocytotic secretion in several different cell types.4Abdullah LH Bundy JT Ehre C Davis CW Mucin secretion and PKC isoforms in SPOC1 goblet cells: differential activation by purinergic agonist and PMA.Am J Physiol Lung Cell Mol Physiol. 2003; 285: L149-L160PubMed Google Scholar, 8Murugappan S Tuluc F Dorsam RT Shankar H Kunapuli SP Differential role of protein kinase C delta isoform in agonist-induced dense granule secretion in human platelets.J Biol Chem. 2004; 279: 2360-2367Crossref PubMed Scopus (92) Google Scholar, 15Ishikawa T Iwasaki E Kanatani K Sugino F Kaneko Y Obara K Nakayama K Involvement of novel protein kinase C isoforms in carbachol-stimulated insulin secretion from rat pancreatic islets.Life Sci. 2005; 77: 462-469Crossref PubMed Scopus (12) Google Scholar, 16Leitges M Gimborn K Elis W Kalesnikoff J Hughes MR Krystal G Huber M Protein kinase C-delta is a negative regulator of antigen-induced mast cell degranulation.Mol Cell Biol. 2002; 22: 3970-3980Crossref PubMed Scopus (115) Google Scholar, 17Cho SH Woo CH Yoon SB Kim JH Protein kinase Cdelta functions downstream of Ca2+ mobilization in FcepsilonRI signaling to degranulation in mast cells.J Allergy Clin Immunol. 2004; 114: 1085-1092Abstract Full Text Full Text PDF PubMed Scopus (55) Google ScholarHere, we further elucidate the role of PKCδ in the mucin secretory pathway in human airway epithelial cells in vitro. The mucin secretory response and phosphorylation of MARCKS were assessed after exposure of well differentiated normal human bronchial epithelial (NHBE) cells to phorbol-12-myristate-13-acetate (PMA), a general PKC activator, or bryostatin 1, a PKCδ/ε activator. In addition, we used the papilloma virus-transformed human bronchial epithelial 1 (HBE1) cell line for molecular manipulations. A dominant-negative PKCδ construct (K376R) transfected into HBE1 cells attenuated PMA-stimulated mucin secretion and MARCKS phosphorylation, whereas a similar dominant-negative PKCε construct was without effect. The results indicate that PKCδ is a key isoform regulating airway mucin secretion, and the mechanism of its action appears to involve phosphorylation of MARCKS protein.Materials and MethodsCulture of Bronchial Epithelial CellsPrimary NHBE cells purchased from Cambrex Bioscience (Walkersville, MD) were expanded and maintained in a humidified air/5% CO2 incubator as described previously.9Li Y Martin LD Spizz G Adler KB MARCKS protein is a key molecule regulating mucin secretion by human airway epithelial cells in vitro.J Biol Chem. 2001; 276: 40982-40990Crossref PubMed Scopus (150) Google Scholar, 11Park JA He F Martin LD Li Y Chorley BN Adler KB Human neutrophil elastase induces hypersecretion of mucin from well-differentiated human bronchial epithelial cells in vitro via a protein kinase C{delta}-mediated mechanism.Am J Pathol. 2005; 167: 651-661Abstract Full Text Full Text PDF PubMed Scopus (96) Google Scholar Cells from at least three separate donors were used in these studies. Passage 31 or 32 of human papilloma virus-transformed human bronchial epithelial cells (HBE1)18Yankaskas JR Haizlip JE Conrad M Koval D Lazarowski E Paradiso AM Rinehart Jr, CA Sarkadi B Schlegel R Boucher RC Papilloma virus immortalized tracheal epithelial cells retain a well-differentiated phenotype.Am J Physiol. 1993; 264: C1219-C1230PubMed Google Scholar was seeded and maintained as described previously. Transient transfection of HBE1 cells was performed after 10 days of culture in air-liquid interface.Exposure of Cells to Inhibitors or SecretagoguesWell differentiated NHBE cells were exposed to test agents both apically and basolaterally for 15 minutes (unless otherwise indicated). Transfected HBE1 cells were exposed to PMA (EMD Biosciences, La Jolla, CA) applied apically only. Cells were preincubated with the PKCδ-selective inhibitor, rottlerin (EMD Biosciences) for 20 minutes before PMA exposure. Initial stock solutions of rottlerin or PMA were prepared in dimethyl sulfoxide, kept at −20°C, and diluted in growth medium directly before use. When cells were exposed to PMA in the presence or absence of rottlerin, PMA was “spiked” into each well at the indicated concentration.Measurement of Mucin SecretionMucin was collected both at baseline and after treatments as described previously.9Li Y Martin LD Spizz G Adler KB MARCKS protein is a key molecule regulating mucin secretion by human airway epithelial cells in vitro.J Biol Chem. 2001; 276: 40982-40990Crossref PubMed Scopus (150) Google Scholar Baseline mucin secretion was used to normalize well-to-well variation. After baseline mucin samples were collected, cells were rested overnight and exposed to test reagents the next day for indicated periods of time. After each treatment period, secreted mucin was collected as the baseline sample and quantified by sandwich enzyme-linked immunosorbent assay using the 17Q2 antibody (Covance Research Products, Berkeley, CA), a monoclonal antibody that reacts specifically with a carbohydrate epitope on human airway mucins.19Lin H Carlson DM St George JA Plopper CG Wu R An ELISA method for the quantitation of tracheal mucins from human and nonhuman primates.Am J Respir Cell Mol Biol. 1989; 1: 41-48Crossref PubMed Scopus (63) Google Scholar The 17Q2 antibody was purified using an ImmunoPure(G) IgG purification kit (Pierce Biotechnology, Rockford, IL) following the manufacturer's protocol and then conjugated with alkaline phosphatase (EMD Biosciences). To account for variability between cultures and experiments, levels of mucin secretion were reported as percentage of the nontreated control. Actual values for mucin released by control cell cultures in these experiments ranged from 40 to 70 ng/ml in NHBE cells and 7 to 10 ng/ml in HBE1 cells.Subcellular Localization of PKC IsoformsActivation of PKCδ was assessed by subcellular fractionation following the protocol described by Kajstura et al20Kajstura J Cigola E Malhotra A Li P Cheng W Meggs LG Anversa P Angiotensin II induces apoptosis of adult ventricular myocytes in vitro.J Mol Cell Cardiol. 1997; 29: 859-870Abstract Full Text PDF PubMed Scopus (375) Google Scholar and subsequent Western blot analysis using a PKCδ-specific antibody (Cell Signaling Technology, Inc., Danvers, MA). Briefly, cells were washed with cold PBS and scraped into lysis buffer [20 mmol/L Tris-Cl (pH 7.5), 1 mmol/L ethylenediamine tetraacetic acid, 100 mmol/L NaCl, 1 mmol/L phenylmethylsulfonyl fluoride, 1 mmol/L dithiothreitol, 1% (v/v) protease inhibitor cocktail, and phosphatase inhibitor cocktail (Sigma, St. Louis, MO)]. The lysate was then sonicated and pelleted at 20,000 × g (Eppendorf 5417 centrifuge) for 40 minutes. The supernatant was collected and kept as the cytosolic fraction at −80°C until used. The remaining pellet was resuspended in lysis buffer containing 1% Triton X-100, sonicated, and centrifuged at 20,000 × g for 40 minutes. The supernatant membrane fraction was stored at −80°C until analyzed by Western blot.Western Blot AnalysisTotal MARCKS, phosphorylated MARCKS, PKCδ, and PKCε protein levels were measured via Western blot. The protein concentrations of cell lysates were quantified by a Bradford assay (Bio-Rad Laboratories, Hercules, CA). Sample lysates were prepared by boiling in 2× SDS sample buffer [125 mmol/L Tris-Cl (pH 6.8), 25% glycerol, 4% SDS, 10% β-mercaptoethanol, and 0.04% bromphenol blue] for 10 minutes. Sample lysates (30 to 60 μg) were loaded on 10 or 12% SDS-polyacrylamide gels and then transferred to a polyvinylidene difluoride membrane (Schleicher & Schuell BioScience, Inc., Keene, NH) following electrophoresis. Polyvinylidene difluoride membranes were blocked with 5% nonfat milk and then probed with an appropriate dilution of primary antibody followed by horseradish peroxidase-conjugated anti-mouse or anti-rabbit antibodies. Chemiluminescent detection was performed using ECL detection reagents (GE Health care Life Sciences, Piscataway, NJ) following the manufacturer's protocol. Amounts of specific proteins in bands were quantified using Labworks image acquisition and analysis software 4.0. (Ultra Violet Products, Ltd., Upland, CA).Antibodies against α-tubulin (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) and E-cadherin (BD Biosciences, San Jose, CA) were used as loading controls for cytosolic and membrane fractions, respectively. Phosphorylated MARCKS (at serine 152/156) was detected with a specific antibody (Cell Signaling Technology, Inc.). After detection, the membrane was stripped in 62.5 mmol/L Tris-Cl (pH 6.5), 10% SDS, and 100 mmol/L β-mercaptoethanol for 10 minutes at room temperature and reprobed with a monoclonal antibody against total MARCKS protein (clone no. 2F12; Upstate, Charlottesville, VA) to verify equal loading.Transient Transfection of PKC ConstructsTransient transfection of vectors overexpressing wild-type or dominant-negative PKCδ and PKCε in HBE1 cells was performed using the FuGene 6 transfection reagent (Roche Applied Science, Indianapolis, IN) following the manufacturer's protocol. The pEGFP-N1 vectors containing a wild-type PKCδ cDNA21Mischak H Pierce JH Goodnight J Kazanietz MG Blumberg PM Mushinski JF Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-alpha and -delta and not by protein kinase C-beta II, -epsilon, -zeta, and -eta.J Biol Chem. 1993; 268: 20110-20115Abstract Full Text PDF PubMed Google Scholar and a dominant-negative PKCδ mutant cDNA [lysine (AAG)→arginine (AGG) mutation, position 376]22Li L Lorenzo PS Bogi K Blumberg PM Yuspa SH Protein kinase Cdelta targets mitochondria, alters mitochondrial membrane potential, and induces apoptosis in normal and neoplastic keratinocytes when overexpressed by an adenoviral vector.Mol Cell Biol. 1999; 19: 8547-8558Crossref PubMed Google Scholar were generously provided by Dr. Arti Shukla (University of Vermont, Burlington, VT) and Dr. Peter Blumberg (National Cancer Institute, Bethesda, MD). The K376→R mutation in the ATP binding site of the catalytic domain has been demonstrated previously to inhibit PKCδ kinase activity.23Li W Yu JC Shin DY Pierce JH Characterization of a protein kinase C-delta (PKC-delta) ATP binding mutant: an inactive enzyme that competitively inhibits wild type PKC-delta enzymatic activity.J Biol Chem. 1995; 270: 8311-8318Crossref PubMed Scopus (89) Google Scholar Briefly, HBE1 cells grown in air/liquid interface were dissociated in versene solution (Invitrogen, Carlsbad, CA) and re-seeded in 12-well culture plates at a density of 1 × 105 cells/cm2. After overnight incubation, cells were transfected with the pEGFP-N1 vector alone or the pEGFP-N1 vector containing either a wild-type or dominant-negative PKCδ cDNA (K376R). Isotype controls for the dominant-negative PKCδ consisted of transient transfection of both wild-type PKCε as well as a catalytically inactive dominant-negative PKCε (K437R) construct-tagged with hemagglutin24Lee YJ Soh JW Jeoung DI Cho CK Jhon GJ Lee SJ Lee YS PKC epsilon -mediated ERK1/2 activation involved in radiation-induced cell death in NIH3T3 cells.Biochim Biophys Acta. 2003; 1593: 219-229Crossref PubMed Scopus (32) Google Scholar (PKCε constructs were kindly provided by Dr. Jae-Won Soh, University of Inha, Inha, Republic of Korea). Cells were subsequently cultured for 48 hours to allow for detectable protein expression. Transfection of PKCδ constructs was confirmed by fluorescent microscopy and assessment of expression of green fluorescence protein (GFP)-tagged PKCδ assessed by Western blot analysis using monoclonal antibodies against PKCδ or GFP (Cell Signaling Technology, Inc.). Transfection of PKCε was confirmed by Western blot analysis using PKCε and HA monoclonal antibodies (Covance Research Products).Cytotoxicity AssayAll treatments used were tested for cytotoxicity using a CytoTox 96 nonradioactive cytotoxicity assay kit (Promega, Madison, WI) according to the manufacturer's instructions. The results were expressed as the ratio of released lactate dehydrogenase to total lactate dehydrogenase. Released lactate dehydrogenase never exceeded 10% of total lactate dehydrogenase with any of the treatments (data not shown).Statistical AnalysisData were expressed as the ratio of treatment to the corresponding vehicle (dimethyl sulfoxide or media) control. Results were evaluated using one-way analysis of variance with Dunnett's test and a Bonferroni posttest correction for multiple comparisons.25Kleinbaum DG Kupper LL Muller KE Applied Regression Analysis and Other Multivariable Methods. PWS-Kent Publishing Co., Boston, MA1988Google Scholar A P value of less than 0.05 was considered significant.ResultsEffect of Rottlerin on PMA-Induced Mucin Secretion and MARCKS Phosphorylation in NHBE CellsTo determine whether PKCδ is an important regulatory molecule in mucin secretion, we investigated the effect of rottlerin, a PKCδ-selective inhibitor, on PMA-induced mucin secretion in well differentiated NHBE cells. As illustrated in Figure 1A, 100 nmol/L PMA provoked translocation of PKCδ from cytosol to membrane in these cells. Inhibition of PKCδ activity by pretreatment of cells with rottlerin (1 to 10 μmol/L) for 20 minutes significantly attenuated PMA-induced mucin secretion in a concentration-dependent manner (Figure 1B). Phosphorylation of MARCKS mediated by PMA in the presence or absence of 15 μmol/L rottlerin was analyzed by Western blot. HNE, previously shown to stimulate mucin secretion in NHBE cells via a rottlerin-inhibitable mechanism,11Park JA He F Martin LD Li Y Chorley BN Adler KB Human neutrophil elastase induces hypersecretion of mucin from well-differentiated human bronchial epithelial cells in vitro via a protein kinase C{delta}-mediated mechanism.Am J Pathol. 2005; 167: 651-661Abstract Full Text Full Text PDF PubMed Scopus (96) Google Scholar was used as an additional control. As shown in Figure 1C, both PMA- and HNE-induced phosphorylation of MARCKS were decreased by pretreatment with rottlerin.Bryostatin 1 Provokes Mucin Secretion and MARCKS Phosphorylation in NHBE CellsBryostatin 1, a PKCδ/ε activator, was used to investigate further the relationship between PKCδ and mucin secretion in NHBE cells. A naturally occurring marine invertebrate-derived cyclic lactone, Bryostatin 1, causes rapid activation of PKCδ and prolonged protection of PKCδ against ubiquitination and proteolysis.26Szallasi Z Denning MF Smith CB Dlugosz AA Yuspa SH Pettit GR Blumberg PM Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.Mol Pharmacol. 1994; 46: 840-850PubMed Google Scholar, 27Heit I Wieser RJ Herget T Faust D Borchert-Stuhltrager M Oesch F Dietrich C Involvement of protein kinase Cdelta in contact-dependent inhibition of growth in human and murine fibroblasts.Oncogene. 2001; 20: 5143-5154Crossref PubMed Scopus (33) Google Scholar Bryostatin 1 interacts with the diacylglycerol binding site on PKC,28Mutter R Wills M Chemistry and clinical biology of the bryostatins.Bioorg Med Chem. 2000; 8: 1841-1860Crossref PubMed Scopus (179) Google Scholar but its complete mode of action has not been fully elucidated, and it can affect PKCs in a cell-type specific manner.29Szallasi Z Smith CB Pettit GR Blumberg PM Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts.J Biol Chem. 1994; 269: 2118-2124Abstract Full Text PDF PubMed Google Scholar As illustrated in Figure 2, exposure of NHBE cells to bryostatin 1 over a range of concentrations (10 to 1000 nmol/L) for 15 minutes resulted in translocation of PKCδ from cytosol to membrane in response to all concentrations tested (Figure 2A). Mucin secretion was also significantly increased by bryostatin 1, with maximal stimulation at 100 nmol/L (Figure 2B). As illustrated in Figure 2C, phosphorylation of MARCKS also was induced in these cells in response to bryostatin 1 (from 10 to 1000 nmol/L) with maximal phosphorylation at 100 nmol/L. None of these treatments induced cytotoxicity as measured by lactate dehydrogenase release assay (data not shown).Figure 2Effect of bryostatin 1, a PKCδ activator, on mucin secretion in well differentiated NHBE cells. NHBE cells were exposed to bryostatin 1 over a range of concentrations from 1 to 1000 nmol/L for 15 minutes. A: PKCδ translocates from cytosol to membrane in response to bryostatin 1. α-Tubulin and E-cadherin were used as controls for the cytosolic and membrane fractions, respectively. Blots are representative of three replicate experiments. B: Bryostatin 1 provokes mucin secretion by NHBE cells in a concentration-dependent manner. Significantly different from vehicle control: *P < 0.05; †P < 0.001; ‡P < 0.005. Data are presented as mean ± SEM (n = 4). C: Phosphorylation of MARCKS in NHBE cells is induced by bryostatin 1 in a concentration-dependent manner. Blots are representative of three replicate experiments.View Large Image Figure ViewerDownload Hi-res image Download (PPT)PKC Activation Stimulates Mucin Secretion in HBE1 CellsTo investigate further a role for PKCδ as a regulator of mucin secretion using molecular manipulation of PKCδ activity, the HBE1 cell line was used. As illustrated in Figure 3, exposure of HBE1 cells to 500 nmol/L PMA for 15 minutes significantly increased mucin secretion (by ∼1.7-fold compared with medium vehicle control) and also induced phosphorylation of MARCKS in these cells.Figure 3HBE-1 cells secrete mucin in response to PKC activation. HBE-1 cells maintained in air/liquid interface were exposed to 100 or 500 nmol/L PMA for 15 minutes. Mucin secretion and phosphorylation of MARCKS were assessed by enzyme-linked immunosorbent assay and Western blot analysis, respectively. A: Mucin secretion is significantly enhanced by PMA at 500 nmol/L (but not 100 nmol/L) in HBE1 cells. *Significantly different from vehicle control (P < 0.05). Data are presented as mean ± SEM (n = 4). B: Phosphorylation of MARCKS is increased by exposure of HBE1 cells to 500 nmol/L PMA. Blots are representative of three replicate experiments.View Large Image Figure ViewerDownload Hi-res image Download (PPT)PKCδ Appears to Regulate Mucin Secretion in Airway Epithelial CellsTransient transfection of the PKCδ and PKCε constructs into HBE1 cells was confirmed by fluorescent microscopy and Western blot analysis. After 48 hours of transfection, GFP expressed in the transfected cells was detected with a fluorescent microscope [Eclipse TE300 (Nikon, Tokyo, Japan) or Axiovert 35 (Zeiss, Welwyn Garden City, UK)] before PMA exposure (data not shown). After exposure to PMA, cells were lysed to detect expression of PKCδ protein fused with GFP via Western blot analysis using anti-PKCδ and -GFP antibodies (data not shown). Transfection of PKCε was confirmed by Western blot analysis using an antibody against PKCε and an HA tag. Transfection efficiency of all constructs and controls was about 20 to 25% as determined by quantification of GFP and X-gal assay for PKCδ and PKCε, respectively (data not shown).As illustrated in Figure 4A, mucin secretion by transfected HBE1 cells was stimulated by exposure to 500 nmol/L PMA. Transfection of HBE1 cells with the dominant-negative PKCδ construct (pEGFP-N1/PKCδK376R) resulted in significant reduction of PMA-induced mucin secretion (∼45%), whereas cells transfected with the wild-type PKCδ construct (pEGFP-N1/PKCδ) showed a significant enhancement of PMA-induced mucin secretion (∼40%) compared with control cells transfected with no DNA or empty vector (pEGFP-N1). In additional control studies, the effects of Bryostatin 1 on both mucin secretion and phosphorylation of MARCKS were markedly attenuated in cells transfected with the dnPKCδ construct (data not shown). PKCε constructs, either wild type or mutated, did not affect the secretory response to PMA. As shown in Figure 4B, phosphorylation of MARCKS in response to PMA was decreased in HBE1 cells transfected with the dominant-negative PKCδ construct (pEGFP-N1/PKCδK376R) but increased in cells transfected with the wild-type PKCδ construct (pEGFP-N1/PKCδ). PKCε constructs, either wild type or mutated, had no effect on PMA-induced MARCKS phosphorylation when transfected into HBE1 cells (Figure 4C).Figure 4Transient transfection of HBE1 cells with a dominant-negative PKCδ construct results in reduction of mucin hypersecretion. HBE1 cells were transiently transfected with empty vector (pEGFP-N1), a wild-type PKCδ construct (pEGFP-N1/PKCδ), or a dominant-negative construct (pEGFP-N1/PKCδK376R) using the FuGene 6 transfection reagent as described in Materials and Methods. As an additional control, a wild-type (pHACE/PKCε) and a dominant-negative PKCε construct (pHACE/PKCεK437R) were also transfected. A: After 48 hours transfection, cells were exposed to 500 nmol/L PMA (lanes 2 to 8) or vehicle control (lane 1) for 15 minutes, at which time media were collected and mucin secretion assessed by enzyme-linked immunosorbent assay. Data are significantly different from media control (*P < 0.05; **P < 0.001); significantly different from cells transfected with n}, number={6}, journal={AMERICAN JOURNAL OF PATHOLOGY}, author={Park, Jin-Ah and Crews, Anne L. and Lampe, William R. and Fang, Shijing and Park, Joungjoa and Adler, Kenneth B.}, year={2007}, month={Dec}, pages={1822–1830} } @article{park_crews_adler_2007, title={Protein kinase C delta regulates airway mucin secretion via phosphorylation of MARCKS protein.}, volume={175}, journal={404nOtfound}, author={Park, J. A. and Crews, A. L. and Adler, K. B.}, year={2007}, pages={A752} } @article{raiford_lin_park_fang_crews_adler_2007, title={Proteomic analysis of mucin granule membrane-associated proteins in human airway epithelial cells: a mechanistic link between MARCKS and hClCA1?}, volume={175}, journal={404nOtfound}, author={Raiford, K. L. and Lin, K. W. and Park, J. and Fang, S. and Crews, A. L. and Adler, K. B.}, year={2007}, pages={A511} } @article{hawkins_birkenheuer_marr_rogala_large_adler_2007, title={Quantification of mucin gene expression in tracheobronchial epithelium of healthy dogs and dogs with chronic bronchitis}, volume={68}, ISSN={["1943-5681"]}, DOI={10.2460/ajvr.68.4.435}, abstractNote={Abstract Objective —To develop a real-time PCR assay for the quantification of mucin gene expression in tracheobronchial brushing specimens from dogs and compare mucin gene expression in specimens from dogs with naturally occurring chronic bronchitis with that in specimens from healthy dogs. Animals —7 healthy dogs and 5 dogs with chronic bronchitis. Procedures —Primers that were designed to span the predicted intron-exon boundaries of a canine MUC5AC-like gene were used to develop a real-time PCR assay for quantification of expression of that gene. Total mRNA was isolated from tracheobronchial brushing specimens obtained from dogs with and without bronchitis during anesthesia; MUC5AC-like gene expression in those samples was quantified by use of the real-time PCR assay. Results —The PCR assay was sensitive and specific for the target sequence, the predicted amino acid sequence of which had greatest homology with human, porcine, and rat MUC5AC. The assay was able to quantify the target over a wide dynamic range. Dogs with chronic bronchitis had a 3.0-fold increase in the quantity of MUC5AC-like mRNA, compared with healthy dogs. Conclusions and Clinical Relevance —The ability to measure mucin gene expression from tracheobronchial brushing specimens collected from client-owned dogs during routine bronchoscopy should prove to be a useful tool for the study of bronchitis in dogs and expand the usefulness of airway inflammation in dogs as a model for bronchitis in humans.}, number={4}, journal={AMERICAN JOURNAL OF VETERINARY RESEARCH}, author={Hawkins, Eleanor C. and Birkenheuer, Adam J. and Marr, Henry S. and Rogala, Allison R. and Large, Edward E. and Adler, Kenneth B.}, year={2007}, month={Apr}, pages={435–440} } @article{wang_adler_erjefalt_bai_2007, title={Role of airway epithelial dysfunction in development of acute lung injury and acute respiratory distress syndrome.}, volume={1}, DOI={10.1586/17476348.1.1.149}, abstractNote={Acute lung injury (ALI) and/or acute respiratory distress syndrome (ARDS) are common and important stages of both pulmonary and systemic critical illnesses. ALI/ARDS is categorized as primary or secondary based on the etiology of the disease. There is increasing evidence to suggest the involvement of airway epithelial cells in the pathogenesis of ALI/ARDS. The airway epithelial cell is a new candidate as a biological target responsible for development of the disease and the role of these cells in the pathogenesis of ALI/ARDS is under investigation. This review describes the importance of the airway epithelial cell in the development of ALI/ARDS, its role as the first line of lung defense facing local and primary challenges, its role as an important player in the development of airway inflammation and remodeling, as an inflammatory promoter for initiating both local and systemic inflammation and as an active producer of several inflammatory and anti-inflammatory mediators. It is hypothesized that airway epithelial cells may contribute to ALI/ARDS via Toll-like receptor-involved mediators, reactive oxygen species-involved reactions and an imbalance between protease and antiprotease activation. The airway epithelial cell may be a valuable therapeutic target for discovering and developing new drugs and/or new therapeutic strategies for ALI/ARDS.}, journal={404nOtfound}, author={Wang, X. and Adler, K. B. and Erjefalt, J. and Bai, C.}, year={2007}, pages={149–155} } @article{waterman_park_crews_adler_2007, title={The (S)?enantiomer of albuterol activates expression of iNOS via activation of NF-kB in primary cultures of normal human bronchial epithelial cells.}, volume={175}, journal={404nOtfound}, author={Waterman, J. T. and Park, J. A. and Crews, A. L. and Adler, K. B.}, year={2007}, pages={A178} } @article{chorley_li_fang_park_adler_2006, title={(R)-Albuterol elicits antiinflammatory effects in human airway epithelial cells via iNOS}, volume={34}, DOI={10.1165/rcmb.2005-03380C}, number={1}, journal={American Journal of Respiratory Cell and Molecular Biology}, author={Chorley, B. N. and Li, Y. H. and Fang, S. J. and Park, J. A. and Adler, K. B.}, year={2006}, pages={119–127} } @article{takashi_park_fang_koyama_parikh_adler_2006, title={A peptide against the N-terminus of myristoylated alanine-rich C kinase substrate inhibits degranulation of human leukocytes in vitro}, volume={34}, ISSN={["1535-4989"]}, DOI={10.1165/rcmb.2006-0030RC}, abstractNote={Leukocytes synthesize a variety of inflammatory mediators that are packaged and stored in the cytoplasm within membrane-bound granules. Upon stimulation, the cells secrete the granule contents via an exocytotic process whereby the granules translocate to the cell periphery, the granule membranes fuse with the plasma membrane, and the granule contents are released extracellularly. We have reported previously that another exocytotic process, release of mucin by secretory cells of the airway epithelium, is regulated by the myristoylated alanine-rich C kinase substrate (MARCKS) (Li Y, Martin LD, Spizz G, Adler KB. MARCKS protein is a key molecule regulating mucin secretion by human airway epithelial cells in vitro. J Biol Chem 2001;276:40982-40990; Singer M, Martin LD, Vargaftig BB, Park J, Gruber AD, Li Y, Adler KB. A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma. Nat Med 2004;10:193-196). In those studies, mucin secretion in vitro and in vivo was attenuated by a synthetic peptide identical to the N-terminus of MARCKS, named the MANS peptide (Li and colleagues, 2001). In this study, we used the MANS peptide to investigate possible involvement of MARCKS in secretion of leukocyte granule proteins. In neutrophils isolated from human blood, phorbol 12-myristate 13-acetate-induced myeloperoxidase release was attenuated in a concentration-dependent manner by MANS but not by equal concentrations of a missense control peptide. In additional studies using human leukocyte cell lines, secretion of eosinophil peroxidase from the eosinophil-like cell line HL-60 clone 15, lysozyme from the monocytic leukemia cell line U937, and granzyme from the lymphocyte natural killer cell line NK-92 were attenuated by preincubation of the cells with MANS but not with the missense control peptide. The results indicate that MARCKS protein may play an important role in the secretion of membrane-bound granules from different leukocytes. MARCKS may be an important component of secretory pathways associated with release of granules by different cell types.}, number={6}, journal={AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY}, author={Takashi, Shuji and Park, Joungjoa and Fang, Shijing and Koyama, Sekiya and Parikh, Indu and Adler, Kenneth B.}, year={2006}, month={Jun}, pages={647–652} } @article{wang_adler_chaudry_ward_2006, title={Better understanding of organ dysfunction requires proteomic involvement}, volume={5}, ISSN={["1535-3893"]}, DOI={10.1021/pr050441n}, abstractNote={Organ dysfunction is defined as a systemic consequence of acute and chronic diseases, a critical and important phase of disease development. The mortality of patients with severe illness is highly correlated with the number and duration of dysfunctional organs. There is still not an efficient and specific therapy to improve the prognosis of patients with organ dysfunction, due to the complexity and severity of the disease. There is a great need to understand molecular mechanisms of the disease, identify disease-related biomarkers, and validate therapeutic effects. Thus, it is important to have a special attention from proteomic scientists to explore the combination between advanced proteomic biotechnology, clinical proteomics, tissue imaging and profiling, and organ dysfunction score systems, to improve the clinical outcomes of these patients. Keywords: organ dysfunction • MODS • proteomics • biomarkers • prognosis}, number={5}, journal={JOURNAL OF PROTEOME RESEARCH}, author={Wang, XD and Adler, KB and Chaudry, IH and Ward, PA}, year={2006}, month={May}, pages={1060–1062} } @article{chorley_crews_li_adler_minnicozzi_martin_2006, title={Differential Muc2 and Muc5ac secretion by stimulated guinea pig tracheal epithelial cells in vitro}, volume={7}, journal={Respiratory Research}, author={Chorley, B. N. and Crews, A. L. and Li, Y. H. and Adler, K. B. and Minnicozzi, M. and Martin, L. D.}, year={2006}, pages={35} } @misc{zhao_adler_bai_tang_wang_2006, title={Epithelial proteomics in multiple organs and tissues: Similarities and variations between cells, organs, and diseases}, volume={5}, ISSN={["1535-3907"]}, DOI={10.1021/pr050389v}, abstractNote={Epithelial cells play an important role in physiological and pathophysiological situations, with organ-, tissue-, type-, and function-specific patterns. Proteome analysis has been used to study epithelial-origin diseases and identify novel prognostic, diagnostic, and therapeutic markers. The present review compares the variation of sample preparation for epithelial proteomic analysis, search similarities, and differences of epithelial proteomics between different cells, locations, and diseases. We focus on specificity of proteomic markers for epithelial-involved diseases. Proteomic alterations in epithelial cell lines were mapped to understand protein patterns, differentiation, oncogenesis, and pathogenesis of epithelial-origin diseases. Changes of proteomic patterns depend on different epithelial cell lines, challenges, and preparation. Epithelial protein profiles associated with intracellular locations and protein function. Epithelial proteomics has been greatly developed to link clinical questions, e.g., disease severity, biomarkers for disease diagnosis, and drug targets. There is an exciting and attractive start to link epithelial proteomics with histology of clinical samples. From the present review, we can find that most of disease-associated investigation of epithelial proteomics has been focused on epithelial-origin cancer. There is a significant gap of epithelial proteomics between acute and chronic organ injury, inflammation, and multiple organ dysfunction. Epithelial proteomics will provide powerful information on the relationships between biological molecules and disease mechanisms. Epithelial proteomics strategies and approaches should become more global, multidimensional, and systemic. Keywords: epithelial cells • proteomics • differentiation • tumorigenesis • cancer • biomarkers}, number={4}, journal={JOURNAL OF PROTEOME RESEARCH}, author={Zhao, H and Adler, KB and Bai, CX and Tang, FD and Wang, XD}, year={2006}, month={Apr}, pages={743–755} } @article{agrawal_subramannian_adler_ram_ghosh_farim_dickey_2006, title={MARCKS related peptide improves airway obstruction related to mucus secretion in a mouse model of asthma.}, volume={3}, journal={404nOtfound}, author={Agrawal, A. and Subramannian, R. and Adler, K. B. and Ram, A. and Ghosh, B. and Farim, M. and Dickey, B. F.}, year={2006}, pages={A713} } @article{adler_fang_lin_park_2006, title={Mechanisms of mucus secretion in the airways.}, volume={2}, DOI={10.1080/17471060500462450}, journal={404nOtfound}, author={Adler, K. B. and Fang, S. and Lin, K-W. and Park, J.}, year={2006}, pages={24–29} } @misc{takashi_parikh_adler_martin_y._2006, title={Methods for regulating inflammatory mediators and peptides useful therein}, volume={7,544,772}, number={2006 Sep. 28}, publisher={Washington, DC: U.S. Patent and Trademark Office}, author={Takashi, S. and Parikh, I. and Adler, K. B. and Martin, L. D. and Y., Li}, year={2006} } @article{park_adler_2006, title={Potential therapy for mucus hypersecretion in chronic obstructive pulmonary disease [translated into Chinese].}, volume={86}, journal={404nOtfound}, author={Park, J. A. and Adler, K. B.}, year={2006}, pages={2890–2892} } @article{park_fang_adler_2006, title={Regulation of airway mucin secretion by MARCKS protein involves the chaperones heat shock protein 70 and Cysteine string protein.}, volume={3}, DOI={10.1513/pats.200603-067ms}, journal={404nOtfound}, author={Park, J. and Fang, S. and Adler, K. B.}, year={2006}, pages={493a} } @article{chorley_adler_2005, title={?2-adrenergic receptor activation with (R)-albuterol attenuates GM-CSF expression via an iNOS-mediated pathway in human bronchial epithelial cells in vitro.}, volume={2}, journal={404nOtfound}, author={Chorley, B. N. and Adler, K. B.}, year={2005}, pages={A757} } @article{takashi_pettersen_park_fang_akley_adler_2005, title={A peptide directed against the N-terminus of MARCKS protein attenuates release of myeloperoxidase (MPO) from human and canine neutrophils in vitro.}, volume={2}, journal={404nOtfound}, author={Takashi, S. and Pettersen, C. A. and Park, J. and Fang, S. and Akley, N. J. and Adler, K. B.}, year={2005}, pages={A633} } @misc{martin_adler_macchione_akley_mckane_2005, title={Culture system for mouse tracheal epithelial cells}, volume={6,933,149}, number={2005 Aug. 23}, publisher={Washington, DC: U.S. Patent and Trademark Office}, author={Martin, L. D. and Adler, K. B. and Macchione, M. and Akley, N. J. and McKane, S. A.}, year={2005} } @article{park_fang_adler_2005, title={Cysteine String Protein is involved in mucin secretion from normal human bronchial epithelial (NHBE) cells in vitro.}, volume={2}, journal={404nOtfound}, author={Park, J. and Fang, S. and Adler, K. B.}, year={2005}, pages={A215} } @article{adler_2005, title={Expert's opinion on potential role of epithelial cells in pathogenesis of organ dysfunction}, volume={1}, ISSN={1747-1060 1747-1079}, url={http://dx.doi.org/10.1080/17471060500219652}, DOI={10.1080/17471060500219652}, number={1}, journal={Journal of Organ Dysfunction}, publisher={Informa UK Limited}, author={Adler, Kenneth B.}, year={2005}, month={Jan}, pages={24–25} } @article{park_chorley_adler_2005, title={Human Neutrophil Elastase provokes mucin secretion by NHBE cells via a Protein Kinase C delta (PKC?)?mediated mechanism.}, volume={2}, journal={404nOtfound}, author={Park, J.-A. and Chorley, B. N. and Adler, K. B.}, year={2005}, pages={A110} } @article{park_he_martin_li_chorley_adler_2005, title={Human neutrophil elastase induces hypersecretion of mucin from well-differentiated human bronchial epithelial cells in vitro via a protein kinase C delta-mediated mechanism}, volume={167}, ISSN={["1525-2191"]}, DOI={10.1016/S0002-9440(10)62040-8}, abstractNote={The presence of mucus obstruction and neutrophil-predominant inflammation in several lung disorders, such as cystic fibrosis, suggests a relationship between neutrophils and excess mucus production. Mechanisms of human neutrophil elastase (HNE)-induced mucin secretion by well-differentiated normal human bronchial epithelial (NHBE) cells maintained in air/liquid interface culture were investigated. HNE increased mucin secretion in a concentration-dependent manner, with maximal stimulation (more than twofold) occurring within a short (15 minutes) time period. Mucins MUC5AC and MUC5B, but not MUC2, were released in response to HNE. Stimulation of mucin secretion required partial elastase enzymatic activity and did not appear to involve a soluble product released by the cells. HNE-stimulated secretion involved activation of protein kinase C (PKC), as HNE exposure rapidly provoked PKC enzymatic activity that was attenuated by the general PKC inhibitors calphostin C and bisindoylmaleimide I. Of the different isoforms, PKCα, δ, ζ, λ, ι, and ε were constitutively expressed in NHBE cells while PKCβ, η, and μ were PMA-inducible. PKCδ was the only isoform to translocate from cytoplasm to membrane in response to HNE. Inhibition of PKCδ attenuated HNE-mediated mucin secretion. The results suggest HNE stimulation of mucin release by human airway epithelial cells involves intracellular activation of PKC, specifically the δ isoform. The presence of mucus obstruction and neutrophil-predominant inflammation in several lung disorders, such as cystic fibrosis, suggests a relationship between neutrophils and excess mucus production. Mechanisms of human neutrophil elastase (HNE)-induced mucin secretion by well-differentiated normal human bronchial epithelial (NHBE) cells maintained in air/liquid interface culture were investigated. HNE increased mucin secretion in a concentration-dependent manner, with maximal stimulation (more than twofold) occurring within a short (15 minutes) time period. Mucins MUC5AC and MUC5B, but not MUC2, were released in response to HNE. Stimulation of mucin secretion required partial elastase enzymatic activity and did not appear to involve a soluble product released by the cells. HNE-stimulated secretion involved activation of protein kinase C (PKC), as HNE exposure rapidly provoked PKC enzymatic activity that was attenuated by the general PKC inhibitors calphostin C and bisindoylmaleimide I. Of the different isoforms, PKCα, δ, ζ, λ, ι, and ε were constitutively expressed in NHBE cells while PKCβ, η, and μ were PMA-inducible. PKCδ was the only isoform to translocate from cytoplasm to membrane in response to HNE. Inhibition of PKCδ attenuated HNE-mediated mucin secretion. The results suggest HNE stimulation of mucin release by human airway epithelial cells involves intracellular activation of PKC, specifically the δ isoform. Neutrophils are involved in a variety of inflammatory lung disorders including chronic bronchitis, bronchiectasis, cystic fibrosis, and probably asthma. In these diseases, the pathological findings of mucus obstruction and neutrophil-predominant inflammation in airways1Fahy JV Kim KW Liu J Boushey HA Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation.J Allergy Clin Immunol. 1995; 95: 843-852Abstract Full Text Full Text PDF PubMed Scopus (568) Google Scholar, 2Stockley RA Role of inflammation in respiratory tract infections.Am J Med. 1995; 99: 8S-13SAbstract Full Text PDF PubMed Scopus (47) Google Scholar, 3Welsh MD Adair BM Foster JC Effect of BVD virus infection on alveolar macrophage functions.Vet Immunol Immunopathol. 1995; 46: 195-210Crossref PubMed Scopus (54) Google Scholar, 4Mohapatra NK Cheng PW Parker JC Paradiso AM Yankaskas JR Boucher RC Boat TF Alteration of sulfation of glycoconjugates, but not sulfate transport and intracellular inorganic sulfate content in cystic fibrosis airway epithelial cells.Pediatr Res. 1995; 38: 42-48Crossref PubMed Scopus (28) Google Scholar, 5Fahy JV Schuster A Ueki I Boushey HA Nadel JA Mucus hypersecretion in bronchiectasis. The role of neutrophil proteases.Am Rev Respir Dis. 1992; 146: 1430-1433Crossref PubMed Scopus (109) Google Scholar, 6Stockley RA Hill SL Morrison HM Starkie CM Elastolytic activity of sputum and its relation to purulence and to lung function in patients with bronchiectasis.Thorax. 1984; 39: 408-413Crossref PubMed Scopus (93) Google Scholar suggest a relationship between neutrophil recruitment/infiltration and excess mucus production and secretion. Neutrophils store three proteases that have been implicated in airway mucin secretion: elastase,7Breuer R Christensen TG Lucey EC Stone PJ Snider GL An ultrastructural morphometric analysis of elastase-treated hamster bronchi shows discharge followed by progressive accumulation of secretory granules.Am Rev Respir Dis. 1987; 136: 698-703Crossref PubMed Scopus (46) Google Scholar, 8Nadel JA Protease actions on airway secretions. Relevance to cystic fibrosis.Ann NY Acad Sci. 1991; 624: 286-296Crossref PubMed Scopus (25) Google Scholar, 9Kim KC Wasano K Niles RM Schuster JE Stone PJ Brody JS Human neutrophil elastase releases cell surface mucins from primary cultures of hamster tracheal epithelial cells.Proc Natl Acad Sci USA. 1987; 84: 9304-9308Crossref PubMed Scopus (124) Google Scholar cathepsin G,10Sommerhoff CP Nadel JA Basbaum CB Caughey GH Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells.J Clin Invest. 1990; 85: 682-689Crossref PubMed Scopus (285) Google Scholar and proteinase-3.11Rao NV Marshall BC Gray BH Hoidal JR Interaction of secretory leukocyte protease inhibitor with proteinase-3.Am J Respir Cell Mol Biol. 1993; 8: 612-616Crossref PubMed Scopus (60) Google Scholar, 12Renesto P Halbwachs-Mecarelli L Nusbaum P Lesavre P Chignard M Proteinase 3. A neutrophil proteinase with activity on platelets.J Immunol. 1994; 152: 4612-4617PubMed Google Scholar Of these, human neutrophil elastase (HNE), a major component of primary or azurophilic granules,13Bainton DF Ullyot JL Farquhar MG The development of neutrophilic polymorphonuclear leukocytes in human bone marrow.J Exp Med. 1971; 134: 907-934Crossref PubMed Scopus (565) Google Scholar is the most widely studied with regard to enhanced mucus secretion. Levels of HNE are elevated in airways of patients with chronic bronchitis and cystic fibrosis,14Fick Jr, RB Naegel GP Squier SU Wood RE Gee JB Reynolds HY Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.J Clin Invest. 1984; 74: 236-248Crossref PubMed Scopus (153) Google Scholar and levels in patients' sputum may exceed 100 μg/ml (3.3 × 10−6 mol/L).15Doring G Goldstein W Botzenhart K Kharazmi A Schiotz PO Hoiby N Dasgupta M Elastase from polymorphonuclear leucocytes: a regulatory enzyme in immune complex disease.Clin Exp Immunol. 1986; 64: 597-605PubMed Google Scholar, 16Goldstein W Doring G Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.Am Rev Respir Dis. 1986; 134: 49-56PubMed Google Scholar, 17Suter S Schaad UB Tegner H Ohlsson K Desgrandchamps D Waldvogel FA Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa.J Infect Dis. 1986; 153: 902-909Crossref PubMed Scopus (104) Google Scholar Purified HNE has been shown to provoke secretion of mucin by isolated airway epithelial cells and glands from several species.7Breuer R Christensen TG Lucey EC Stone PJ Snider GL An ultrastructural morphometric analysis of elastase-treated hamster bronchi shows discharge followed by progressive accumulation of secretory granules.Am Rev Respir Dis. 1987; 136: 698-703Crossref PubMed Scopus (46) Google Scholar, 8Nadel JA Protease actions on airway secretions. Relevance to cystic fibrosis.Ann NY Acad Sci. 1991; 624: 286-296Crossref PubMed Scopus (25) Google Scholar, 10Sommerhoff CP Nadel JA Basbaum CB Caughey GH Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells.J Clin Invest. 1990; 85: 682-689Crossref PubMed Scopus (285) Google Scholar, 18Kim KC Nassiri J Brody JS Mechanisms of airway goblet cell mucin release: studies with cultured tracheal surface epithelial cells.Am J Respir Cell Mol Biol. 1989; 1: 137-143Crossref PubMed Scopus (46) Google Scholar Although there have been suggestions that interactions between HNE and epithelial cell surfaces may be involved in the response,9Kim KC Wasano K Niles RM Schuster JE Stone PJ Brody JS Human neutrophil elastase releases cell surface mucins from primary cultures of hamster tracheal epithelial cells.Proc Natl Acad Sci USA. 1987; 84: 9304-9308Crossref PubMed Scopus (124) Google Scholar, 19Takeyama K Agusti C Ueki I Lausier J Cardell LO Nadel JA Neutrophil-dependent goblet cell degranulation: role of membrane-bound elastase and adhesion molecules.Am J Physiol. 1998; 275: L294-L302PubMed Google Scholar intracellular mechanisms and signaling pathways associated with HNE-induced mucin hypersecretion have not been elucidated. In this study, well-differentiated primary normal human tracheobronchial epithelial (NHBE) cells maintained in vitro in air/liquid interface were exposed to HNE, and the secretory response assessed. Elastase proved to be a potent mucin secretagogue for NHBE cells, eliciting a robust (greater than twofold) increase in mucin secretion within 15 minutes. The mucin gene products released included those of MUC5AC and MUC5B, but not of MUC2. The mechanism appeared to involve activation of protein kinase C (PKC), as HNE exposure rapidly provoked phosphorylation of MARCKS (myristoylated alanine-rich C kinase substrate) protein, a cellular substrate of PKC, and the mucin secretory response to HNE was attenuated by two different PKC inhibitors. Additional studies provided compelling evidence that PKCδ is the specific PKC isoform involved in the secretory pathway. All chemicals were of analytical grade or higher. NHBE cells, bronchial epithelial basal medium, and supplements for air/liquid interface cell cultures were purchased from Cambrex (San Diego, CA). Endotoxin-free HNE purified from human sputum was purchased from Elastin Products Company (EPC, Owensville, MO). Cytotoxicity was evaluated with CytoTox 96 nonradioactive cytotoxicity assay kits obtained from Promega Corp. (Madison, WI). A specific HNE substrate, MeO-SUC-AL-AL-PRO-VAL-PNA, and an HNE inhibitor, chloromethyl ketone-modified tetrapeptide (CMK), also were purchased from EPC and the HNE inhibitor elastatinal was obtained from Calbiochem (La Jolla, CA). 17Q2 pan mucin antibody was purchased from Babco (Richmond, CA) and anti-MUC5AC (45M1) was purchased from Neomarkers (Fremont, CA). A monoclonal antibody (11C1) against human MUC5B was generously provided by Dr. Reen Wu, University of California at Davis, Davis, CA. The epitope for this antibody, which was generated from the secreted mucin of well-differentiated airway epithelial cells, is not known, but by immunohistochemical staining and Western blot analysis, it appears to recognize the MUC5B peptide. A monoclonal antibody that cross reacts with human MUC2, raised against the guinea pig 522-bp gene sequence analogous to the human D4 domain located in the carboxy-terminal region of the Muc2 gene sequence established previously in our laboratory, was used to detect MUC2 mucins.20Li Y Martin LD Minnicozzi M Greenfeder S Fine J Pettersen CA Chorley B Adler KB Enhanced expression of mucin genes in a guinea pig model of allergic asthma.Am J Respir Cell Mol Biol. 2001; 25: 644-651Crossref PubMed Scopus (32) Google Scholar An ImmunoPure (G) IgG purification kit used for purification of antibodies for enzyme-linked immunosorbent assay (ELISA) was from Pierce (Rockford, IL). For Western blot analysis of PKC isoforms expressed in NHBE cells, a PKC sampler kit and E-cadherin antibody were obtained from BD Biosciences (San Jose, CA). Goat anti-PKCζ and mouse anti-α-tubulin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies against phosphorylated (ser) PKC substrate and phosphorylated MARCKS were from Cell Signaling Technology (Beverly, MA). Horseradish peroxidase-conjugated goat anti-mouse IgG and donkey anti-goat IgG also were purchased from Santa Cruz Biotechnology. Horseradish peroxidase-conjugated goat anti-rabbit IgG was purchased from Upstate Biotechnology (Lake Placid, NY). Enhanced chemiluminescence development kits and Hyperfilm were from Amersham Pharmacia Biotech (Piscataway, NJ). All PKC-related inhibitors (ie, calphostin C, bisindoylmaleimide, PKC epsilon and zeta inhibitor peptides, rottlerin) were purchased from Calbiochem. A PepTag assay for nonradioactive detection of PKC activity was purchased from Promega. Other chemical reagents were purchased from Sigma-Aldrich (St. Louis, MO). Transwell-Clear culture inserts and high-binding 96-well assay plates were purchased from Corning Inc. (Corning, NY). Primary cultures of NHBE cells were established using an air/liquid interface cell culture system described previously.21Li Y Martin LD Spizz G Adler KB MARCKS protein is a key molecule regulating mucin secretion by human airway epithelial cells in vitro.J Biol Chem. 2001; 276: 40982-40990Crossref PubMed Scopus (155) Google Scholar Briefly, NHBE cells were expanded once and cells collected and frozen in liquid nitrogen (referred to as passage-2 cells). Air/liquid interface cultures of NHBE cells were established on Transwell-Clear culture inserts thin-coated with rat-tail type I collagen. The basic medium used for NHBE cells was a 1:1 mixture of bronchial epithelial basal medium and high glucose (4.5 g/L) Dulbecco's modified Eagle's medium. The complete medium was composed of basic medium containing a final concentration of 0.5 ng/ml human recombinant epidermal growth factor, 0.5 μg/ml hydrocortisone, 5 μg/ml insulin, 10 μg/ml transferrin, 0.5 μg/ml epinephrine, 6.5 ng/ml triiodothyronine, 50 μg/ml gentamicin, and 50 ng/ml amphotericin-B. In addition, the media contained 0.13 mg/ml bovine pituitary extract made according to the protocol of Bertolero and colleagues,22Bertolero F Kaighn ME Gonda MA Saffiotti U Mouse epidermal keratinocytes. Clonal proliferation and response to hormones and growth factors in serum-free medium.Exp Cell Res. 1984; 155: 64-80Crossref PubMed Scopus (61) Google Scholar 5 × 10−8 mol/L all-trans retinoic acid, 1.5 μg/ml bovine serum albumin, and 20 U/ml nystatin. Frozen NHBE cells were recovered and seeded at a density of ∼2 × 104 cells/cm2 onto the apical surface of the inserts. Media were changed the next day, then every other day until the cells reached ∼90% confluence. At this point, the air/liquid interface was established by removing the apical media, whereas basolateral media were changed daily for up to 21 days. A mucin phenotype was observed at ∼14 days in culture (∼7 days in air-liquid interface culture) and cilia were apparent by 18 days in culture. Mucin secretion reached maximal levels at ∼18 days in culture, so cells cultured for ∼18 to 21 days were used for the experiments described below. HNE stock was made as 10 mg/ml (339 μmol/L) in a 1:1 mixture of glycerol and 0.02 mol/L NaOAc, pH 5.0. The stock was diluted into the culture medium to the final concentration indicated. In all studies, the above solvent appropriately diluted was used as a negative control. NHBE cells were exposed to HNE from both apical and basolateral sides for 15 minutes (unless otherwise indicated). At the end of each treatment, apical medium containing the secreted mucin was collected and quantified. Briefly, 0.25 ml of media containing secreted mucin was collected, 0.5 ml of 1 mmol/L dithiothreitol in phosphate-buffered saline (PBS) was added into each well, and the plates were gently agitated and allowed to stand for 3 minutes before the dithiothreitol/PBS plus mucin was collected in the same tube. Finally, 0.5 ml of 10 μmol/L CMK in PBS was added and collected the same way. Approximately 1.25 ml of the collected mucin mixture with dithiothreitol and CMK was centrifuged at 8000 rpm for 5 minutes to remove cell debris, and then collected in a fresh tube. Phenylmethyl sulfonyl fluoride was added to a final concentration of 1 mmol/L. Baseline and treatment mucin secretions were collected from each culture plate. Baseline mucin secretion was collected to normalize variations from well to well, and to control for possible release of mucin in response to the stress of media change or washing. After the baseline mucin secretion sample was collected, the cells were rested overnight and exposed to test agents the next day for indicated periods of time. Mucin samples were quantified using specific ELISA methods. Firstly, total mucin was quantified by a double-sandwich ELISA using a pan-mucin antibody, 17Q2, that cross reacts with a carbohydrate epitope on human mucins, as described previously.21Li Y Martin LD Spizz G Adler KB MARCKS protein is a key molecule regulating mucin secretion by human airway epithelial cells in vitro.J Biol Chem. 2001; 276: 40982-40990Crossref PubMed Scopus (155) Google Scholar Additional studies were performed using ELISAs for secreted protein products of the mucin genes MUC5AC, MUC5B, and MUC2 to determine which mucin gene products were being released on exposure to HNE. MUC5AC was measured via ELISA as described by Takeyama and colleagues23Takeyama K Dabbagh K Lee HM Agusti C Lausier JA Ueki IF Grattan KM Nadel JA Epidermal growth factor system regulates mucin production in airways.Proc Natl Acad Sci USA. 1999; 96: 3081-3086Crossref PubMed Scopus (522) Google Scholar using the 45M1 antibody. MUC5B protein was assayed via a standard double-sandwich ELISA method using the 11C1 monoclonal antibody against MUC5B provided by Dr. Reen Wu, University of California, Davis, Davis, CA, as described previously.24Groneberg DA Eynott PR Oates T Lim S Wu R Carlstedt L Nicholson AG Chung KF Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung.Respir Med. 2002; 96: 81-86Abstract Full Text PDF PubMed Scopus (154) Google Scholar, 25Crowther JR ELISA. Theory and practice.Methods Mol Biol. 1995; 42: 1-218PubMed Google Scholar The MUC2 gene product was quantified by modification of an ELISA as described previously.20Li Y Martin LD Minnicozzi M Greenfeder S Fine J Pettersen CA Chorley B Adler KB Enhanced expression of mucin genes in a guinea pig model of allergic asthma.Am J Respir Cell Mol Biol. 2001; 25: 644-651Crossref PubMed Scopus (32) Google Scholar HNE activity assays were performed following the manufacturer's protocol (EPC). HNE substrate was prepared in substrate buffer (Tris-NaCl buffer: 0.1 mol/L Tris, pH 7.5, containing 0.5 mol/L NaCl and 0.01% Na3N). Briefly, 3 ml of substrate solution at 25°C was added to test tubes, 1.0 μg of HNE then was added, and the developed color was read immediately and continuously thereafter at 1 minute intervals. Elastase activity was reflected by the rate increase in absorbance in time units (minutes). Color development was read at 410 nm on a spectrophotometer UV160U (Shimadzu, Kyoto, Japan). The specific activity of HNE was expressed as U/mg, and results expressed as percentage of activity of native HNE for each treatment. Effects of enzymatic inhibition of HNE were investigated using three different elastase inhibitors: 1) elastatinal, a natural HNE inhibitor produced by Actinomycetes;26Umezawa H Structures and activities of protease inhibitors of microbial origin.Methods Enzymol. 1976; 45: 678-695Crossref PubMed Scopus (303) Google Scholar 2) CMK, a synthetic tetrapeptide;27Rees DD Brain JD Wohl ME Humes JL Mumford RA Inhibition of neutrophil elastase in CF sputum by L-658,758.J Pharmacol Exp Ther. 1997; 283: 1201-1206PubMed Google Scholar and 3) α1-antitrypsin (α1-AT), a physiological HNE inhibitor.28Gadek JE Fells GA Zimmerman RL Rennard SI Crystal RG Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.J Clin Invest. 1981; 68: 889-898Crossref PubMed Scopus (311) Google Scholar The inhibitors were added directly to HNE, incubated for 15 minutes at 37°C, and then added directly to the cells for another 15 minutes. At the end of this exposure, secreted mucin was collected and quantified as described above. To determine whether HNE enzymatic activity was directly required for stimulated mucin secretion, or if a secondary product(s) released by NHBE cells after exposure to HNE could be involved in the secretory response, NHBE cells were exposed to HNE (or vehicle) for 5 minutes. After exposure, the conditioned medium was collected and treated with 5 μmol/L of the HNE enzymatic inhibitor, α1-AT, for 15 minutes, at which time this α1-AT-treated medium was added to a new set of NHBE cells and effects on mucin secretion quantified as described above. The PKC inhibitors, bisindolylmaleimide I (10, 100, 1000 nmol/L)29Martiny-Baron G Kazanietz MG Mischak H Blumberg PM Kochs G Hug H Marme D Schachtele C Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976.J Biol Chem. 1993; 268: 9194-9197Abstract Full Text PDF PubMed Google Scholar or calphostin C (5, 50, 500 nmol/L)30Takahashi I Saitoh Y Yoshida M Sano H Nakano H Morimoto M Tamaoki T UCN-01 and UCN-02, new selective inhibitors of protein kinase C. II. Purification, physico-chemical properties, structural determination and biological activities.J Antibiot (Tokyo). 1989; 42: 571-576Crossref PubMed Scopus (168) Google Scholar were used to determine PKC involvement in HNE-induced mucin secretion. NHBE cells were preincubated with these agents (or vehicle control) for 15 minutes, then HNE was added for another 15 minutes before mucin secretion was quantified as described above. PKC activity in NHBE cells after exposure to HNE was assessed using a PepTag assay for nonradioactive detection of PKC (following the manufacturer's protocol). Briefly, 10 μg of protein extracted from each treatment of NHBE cells was added into the PKC reaction buffer (20 mmol/L HEPES, pH 7.4, 1.3 mmol/L CaCl2, 1 mmol/L dithiothreitol, 10 mmol/L MgCl2, 1 mmol/L ATP) containing 1 mg/ml phosphatidylserine and PepTag C1 PKC substrate peptide (P-L-S-R-T-L-S-V-A-A-K) conjugated with fluorescent dye, and incubated for 30 minutes at 30°C. The reaction was stopped by boiling at 100°C for 10 minutes. Reaction mixtures were separated on 0.8% agarose gels and proteins quantified by Labworks image acquisition and analysis software (UVP Bioimaging System, Upland, CA). Phosphorylation of MARCKS was detected by Western blot using an antibody against phophospecific-MARCKS. After treatments, NHBE cells were washed with ice-cold PBS twice and then scraped into lysis buffer (50 mmol/L Tris, pH 7.5, 1 mmol/L ethylenediamine tetraacetic acid, 100 mmol/L NaCl, 1 mmol/L phenylmethyl sulfonyl fluoride) using a rubber policemen. The collected cells were lysed by sonication. For separation of cytosolic and membrane fractions, the lysates were spun at 400,000 × g in a Sorvall Discovery 100S ultracentrifuge (Sorvall, Inc. Newtown, CT) for 1 hour. The supernatant was reserved as the cytosolic sample. The pellet was resuspended in the same lysis buffer containing 0.05% Triton-100, dissolved by sonication, and incubated on ice for 30 minutes. After incubation, the same ultracentrifugation as described above was performed on the pellet mixture, and the supernatant separated from the pellet mixture was reserved as the membrane fraction. For preparation of whole cell crude lysates, the disrupted cellular mixture was centrifuged at 15,000 rpm in an Eppendorf 5417R centrifuge (Eppendorf Corp., Hamburg, Germany) for 1 hour at 4°C. The supernatant was collected as the whole crude NHBE cell lysate. The protein concentration of cell lysate samples was quantified by a Bradford assay (Bio-Rad Laboratories, Hercules, CA). Each sample was boiled in 2× sodium dodecyl sulfate-polyacrylamide gel electrophoresis sample buffer for 10 minutes, loaded on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels, and transferred to a polyvinylidene difluoride membrane (Micron Separation Inc., Westborough, MA). After blocking with 5% skim milk, the antigen was captured by the specific PKC antibody and further amplified by binding to horseradish peroxidase-conjugated anti-mouse or anti-rabbit antibodies. Anti-α-tubulin and E-cadherin antibodies were used for cytosolic and membrane controls, respectively, for each sample. Final development was accomplished by the enhanced chemiluminescence method. The amount of each PKC isoform was analyzed by Labworks image acquisition and analysis software. Because the studies above indicated that PKCδ was the only isoform to translocate to membranes in response to HNE, additional studies were performed with rottlerin, an inhibitor of PKCδ and θ.31Gschwendt M Muller HJ Kielbassa K Zang R Kittstein W Rincke G Marks F Rottlerin, a novel protein kinase inhibitor.Biochem Biophys Res Commun. 1994; 199: 93-98Crossref PubMed Scopus (767) Google Scholar (Because PKCθ was not expressed in NHBE cells under basal or stimulated conditions, rottlerin is referred to below as a specific inhibitor of PKCδ). Rottlerin has the following potency against PKC isoforms: PKC δ (IC50 = 3 to 6 μmol/L); PKCθ (IC50 = 50 μmol/L); PKCα, PKCβ, and PKC γ (IC50 = 30 to 42 μmol/L); PKCε, PKCη, and PKCζ (IC50 = 80 to 100 μmol/L). It also can inhibit CaM kinase III (IC50 = 5.3 μmol/L).31Gschwendt M Muller HJ Kielbassa K Zang R Kittstein W Rincke G Marks F Rottlerin, a novel protein kinase inhibitor.Biochem Biophys Res Commun. 1994; 199: 93-98Crossref PubMed Scopus (767) Google Scholar, 32Villalba M Kasibhatla S Genestier L Mahboubi A Green DR Altman A Protein kinase C cooperates with calcineurin to induce fas ligand expression during activation-induced T cell death.J Immunol. 1999; 163: 5813-5819PubMed Google Scholar Cells were preincubated with rottlerin (1.5 μmol/L; IC50 = 3 to 6 μmol/L) for 20 minutes before exposure to HNE, and effects on PKC activity [using detection of phosphorylated (ser) PKC substrate] and on HNE-induced mucin secretion were assessed. As additional controls, the potential role of other PKC isoforms present in these cells was assessed: cells were exposed to the following specific inhibitors for 15 minutes before exposure to HNE and assay for mucin secretion: The PKCα/β inhibitor, Gö 6976 (10 nmol/L; IC50 = 2 ∼ 6 nmol/L);29Martiny-Baron G Kazanietz MG Mischak H Blumberg PM Kochs G Hug H Marme D Schachtele C Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976.J Biol Chem. 1993; 268: 9194-9197Abstract Full Text PDF PubMed Google Scholar a PKCζ peptide inhibitor (50 μmol/L; Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu; IC50 = 10 μmol/L);33Bandyopadhyay G Standaert ML Galloway L Moscat J Farese RV Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes.Endocrinology. 1997; 138: 4721-4731Crossref PubMed Scopus (210) Google Scholar or a PKCε peptide inhibitor (3 ∼ 300 μmol/L; Glu-Ala-Val-Ser-Leu-Lys-Pro-Thr; IC50 = 80.3 μmol/L).34Johnson JA Gray MO Chen CH Mochly-Rosen D A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function.J Biol Chem. 1996; 271: 24962-24966Crossref PubMed Scopus (343) Google Scholar, 35Mendez CF Leibiger IB Leibiger B Hoy M Gromada J Berggren PO Bertorello AM Rapid association of protein kinase C-epsilon with insulin granules is essential for insulin exocytosis.J Biol Chem. 2003; 278: 44753-44757Crossref PubMed Scopus (59) Google Scholar Data were expressed as the ratio of treatment to the corresponding vehicle control. Results were evaluated using one-way analysis of variance with Bonferroni posttest correction for multiple comparisons.36Kleinbaum DG Kupper LL Muller KE Applied Regression Analysis and Other Multivariable Methods. PWS-Kent Pub. Co., Boston1988: 341-386Google Scholar A P value of <0.05 was considered significant. All reagents used were tested for cytotoxicity using a Promega Cytotox 96 nonradioactive cytotoxicity assay kit according to the manufacturer's instructions. The data were expressed as the ratio of released lactate dehydrogenase to total lactate dehydrogenase. Released lactate dehydrogenase never exceeded 10% of total lactate dehydrogenase (data not shown) in any of the experiments below. As illustrated in Figure 1, HNE stimulated mucin secretion by NHBE cells. Maximal mucin secretion was elicited after 15 minutes exposure to HNE (Figure 1A) so this time point was chosen for additional experiments. HNE increased mucin secretion in a concentration-dependent manner, with 0.01 to 1.0 μmol/L HNE increasing secretion significantly over vehicle control (Figure 1B). Secretion of major gel-forming mucins, including MUC2, MUC5AC, and MUC5B, was investigated after exposure to HNE. As illustrated in Figure 2, HNE enhanced release of both MUC5AC and MUC5B mucins from NHBE cells in a concentration-dependent manner. Secretion of MUC2 mucin was significantly decreased by HNE. Elastatinal appeared to be the weakest of the three HNE inhibitors used in this study because the highest concentration used, 100 μmol/L, blocked only 50% of HNE enzymatic activity and did not affect HNE-stimulated mucin secretion (Figure 3A). CMK proved to be a more potent HNE enzymatic inhibitor because 50 μmol/L CMK completely blocked the enzymatic activity of 1 μmol/L HNE, whereas lower concentrations partially inhibited HNE activity in a concentration-dependent manner. CMK also showed an inhibitory effect on HNE-stimulated mucin secretion in a concentration-dependent manner w}, number={3}, journal={AMERICAN JOURNAL OF PATHOLOGY}, author={Park, JA and He, F and Martin, LD and Li, YH and Chorley, BN and Adler, KB}, year={2005}, month={Sep}, pages={651–661} } @article{singer_martin_vargaftig_park_gruber_li_adler_2004, title={A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma}, volume={10}, ISSN={["1546-170X"]}, DOI={10.1038/nm983}, abstractNote={Mucus hypersecretion is a crucial feature of pulmonary diseases such as asthma, chronic bronchitis and cystic fibrosis. Despite much research, there is still no effective therapy for this condition. Recently, we showed that the myristoylated, alanine-rich C-kinase substrate (MARCKS) protein is required for mucus secretion by human bronchial epithelial cells in culture. Having synthesized a peptide corresponding to the N-terminal domain of MARCKS, we now show that the intratracheal instillation of this peptide blocks mucus hypersecretion in a mouse model of asthma. A missense peptide with the same amino acid composition has no effect. Based on quantitative histochemical analysis of the mouse airways, the peptide seems to act by blocking mucus release from goblet cells, possibly by inhibiting the attachment of MARCKS to membranes of intracellular mucin granules. These results support a pivotal role for MARCKS protein, specifically its N-terminal region, in modulating this secretory process in mammalian airways. Intratracheal administration of this MARCKS-related peptide could therapeutically reduce mucus secretion in the airways of human patients with asthma, chronic bronchitis and cystic fibrosis.}, number={2}, journal={NATURE MEDICINE}, author={Singer, M and Martin, LD and Vargaftig, BB and Park, J and Gruber, AD and Li, YH and Adler, KB}, year={2004}, month={Feb}, pages={193–196} } @misc{martin_adler_li_2004, title={Blocking peptide for inflammatory cell secretion}, volume={WO/2003/000027}, number={2004 Sep. 16}, publisher={Washington, DC: U.S. Patent and Trademark Office}, author={Martin, L. D. and Adler, K. B. and Li, Y}, year={2004} } @article{chorley_adler_2004, title={Inducible nitric oxide synthase/protein kinase G signaling pathway suppresses granulocyte macrophage colony stimulating factor transcription in normal human bronchial epithelial cells in vitro}, volume={169}, journal={American Journal of Respiratory and Critical Care Medicine}, author={Chorley, B. N. and Adler, K. B.}, year={2004}, pages={A421} } @article{park_fang_gruber_adler_2004, title={MARCKS protein interaction with the ?secretory module? regulates airway mucin secretion.}, volume={169}, journal={American Journal of Respiratory and Critical Care Medicine}, author={Park, J. and Fang, S. and Gruber, A. D. and Adler, K. B.}, year={2004}, pages={A535} } @article{hashimoto_graham_ho_adler_collins_olson_zhou_suzutani_jones_goleniewska_et al._2004, title={Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and Gob-5}, volume={170}, ISSN={["1535-4970"]}, DOI={10.1164/rccm.200301-030OC}, abstractNote={Respiratory syncytial virus (RSV) is associated with wheezing and childhood asthma. We previously reported that RSV infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin (OVA)-sensitized mice. In addition, allergically sensitized RSV-infected (OVA/RSV) mice had more abundant airway epithelial mucus production compared with OVA mice 14 days after infection, whereas there was almost no mucus in mice that were only RSV infected. We hypothesized that this increased mucus was associated with mucosal expression of Muc5ac, a mucus gene expression in airways, and gob-5, a member of the Ca2+-activated chloride channel family. By histochemical analysis, we found that there was significantly increased staining for gob-5 and Muc5ac in the airways of OVA/RSV mice compared with either OVA mice or allergically sensitized mice that were challenged with inactivated RSV, and virtually no detectable staining in the RSV group. These findings were confirmed by Western blot analysis. The increased mucus expression in the OVA/RSV group was associated with increased lung levels of interleukin-17, a factor known to stimulate airway mucin gene expression. The impact of virus infection combined with allergic inflammation on mucus production may partially explain the more severe disease and airway hyperresponsiveness associated with RSV in the setting of atopy.}, number={3}, journal={AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE}, author={Hashimoto, K and Graham, BS and Ho, SB and Adler, KB and Collins, RD and Olson, SJ and Zhou, WS and Suzutani, T and Jones, PW and Goleniewska, K and et al.}, year={2004}, month={Aug}, pages={306–312} } @article{fang_park_adler_2004, title={Small interfering RNA?s directed against MARCKS protein and Heat Shock Protein 70 (Hsp70) attenuate mucin secretion in human airway epithelial cells in vitro.}, volume={169}, journal={American Journal of Respiratory and Critical Care Medicine}, author={Fang, S. and Park, J. and Adler, K. B.}, year={2004}, pages={A712} } @article{vargaftig_singer_martin_li_adler_2003, title={A myristoylated peptide directed against the N-terminal region of MARCKS protein inhibits mucin secretion in ovalbumin sensitized/challenged mice in vivo.}, volume={167}, journal={American Journal of Respiratory and Critical Care Medicine}, author={Vargaftig, B. and Singer, M. and Martin, L. D. and Li, Y. and Adler, K. B.}, year={2003}, pages={A17} } @article{lin_park_li_adler_2003, title={Activation of protease-activated receptors?2 (PAR-2) is not associated with enhanced mucin secretion by well-differentiated normal human bronchial epithelial cells in vitro.}, volume={167}, journal={American Journal of Respiratory and Critical Care Medicine}, author={Lin, K. W. and Park, J. J. and Li, Y. and Adler, K. B.}, year={2003}, pages={A204} } @article{chorley_martin_crews_li_adler_2003, title={Differential effects of albuterol isomers on normal human bronchial epithelial cells in vitro.}, volume={167}, journal={American Journal of Respiratory and Critical Care Medicine}, author={Chorley, B. N. and Martin, L. D. and Crews, A. C. and Li, Y. and Adler, K. B.}, year={2003}, pages={A205} } @article{krunkosky_martin_fischer_voynow_adler_2003, title={Effects of TNF alpha on expression of ICAM-1 in human airway epithelial cells in vitro: Oxidant-mediated pathways and transcription factors}, volume={35}, ISSN={["1873-4596"]}, DOI={10.1016/S0891-5849(03)00498-2}, abstractNote={We demonstrate that two different cell-permeable antioxidants, pyrrolidine dithiocarbamate (PDTC) and dimethylthiourea (DMTU), inhibit TNFalpha-induced ICAM-1 surface and gene expression in primary cultures of differentiated normal human bronchial epithelial (NHBE) cells. In addition, TNFalpha stimulates binding of nuclear proteins to the nuclear factor kappa beta (NFkappaB) and the CAAT/enhancer binding protein (C/EBP) consensus sites in the ICAM-1 promoter in these cells. Because these transcription factors have been suggested to be oxidant-sensitive and important in ICAM-1 expression, the potential involvement of reactive oxygen species (ROS) in the response to TNFalpha was investigated. Interestingly, neither PDTC nor DMTU altered binding of NFkappaB complexes. In contrast, either the proteasome inhibitor carbobenzoxy-L-leucy-L-leucy-L-leucinal (MG 132) or the IkappaBalpha inhibitor BAY 11-7082 ablated TNFalpha-induced ICAM-1 gene expression and MG132 inhibited TNFalpha-induced NFkappaB complexes. Surprisingly, either PDTC or DMTU inhibited the binding of TNFalpha-enhanced C/EBP complexes to the consensus site directly adjacent to the NFkappaB site. These results suggest that although TNFalpha enhances binding of C/EBP and NFkappaB complexes in NHBE cells, C/EBP binding seems to involve an oxidant-dependent mechanism, whereas activation of NFkappaB complexes utilizes the ubiquitin-proteasome pathway, a mechanism that seems to be unaltered by the presence of antioxidants. Because interference with either signaling pathway abrogates TNFalpha-induced ICAM-1 expression, activation of both complexes seems to be involved in this response to TNFalpha, but this activation occurs via different intracellular pathways.}, number={9}, journal={FREE RADICAL BIOLOGY AND MEDICINE}, author={Krunkosky, TM and Martin, LD and Fischer, BM and Voynow, JA and Adler, KB}, year={2003}, month={Nov}, pages={1158–1167} } @article{park_he_li_martin_adler_2003, title={Human neutrophil elastase provokes release of MUC5B mucin from normal bronchial epithelial cells in vitro via a PKC-dependent mechanism.}, volume={167}, journal={American Journal of Respiratory and Critical Care Medicine}, author={Park, J. A. and He, F. and Li, Y. and Martin, L. D. and Adler, K. B.}, year={2003}, pages={A203} } @article{singh_daniels_winsett_richards_doerfler_hatch_adler_gilmour_2003, title={Phenotypic comparison of allergic airway responses to house dust mite in three rat strains}, volume={284}, ISSN={["1522-1504"]}, DOI={10.1152/ajplung.00287.2002}, abstractNote={Brown Norway (BN) rats develop a robust response to antigens in the lung, characterized by a large increase in allergen-specific immune function and pulmonary eosinophilia. The objective of this study was to investigate alternative models by determining whether other rat strains could be sensitized to house dust mite (HDM) antigen and whether the allergic disease process could be worsened with repeated allergen exposure. In general, BN rats sensitized by either subcutaneous or intratracheal routes exhibited increased pulmonary allergy compared with Sprague-Dawley (SD) and Lewis (L) rats. Multiple intratracheal allergen exposures incrementally increased HDM-specific immune function in BN rats but progressively decreased eosinophil recruitment and markers of lung injury. SD rats had more moderate responses, whereas L rats were relatively unresponsive. Because BN rats developed stronger clinical hallmarks of allergic asthma under various immunization regimes compared with SD and L rats, we conclude that the BN is the most appropriate strain for studying allergic asthma-like responses in rats. Phenotypic differences in response to HDM were associated with differences in the Th1/Th2 cytokine balance and antioxidant capacity.}, number={4}, journal={AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY}, author={Singh, P and Daniels, M and Winsett, DW and Richards, J and Doerfler, D and Hatch, G and Adler, KB and Gilmour, MI}, year={2003}, month={Apr}, pages={L588–L598} } @article{booth_newcomb_mckane_crews_adler_bonner_martin_2003, title={Proliferation of the airway epithelium in asthma - Are inflammatory cells required?}, volume={123}, ISSN={["0012-3692"]}, DOI={10.1378/chest.123.3_suppl.384S}, abstractNote={Asthma is associated with a T helper type 2 phenotype in which interleukin (IL)-4, IL-5, and IL-13 predominate. In addition, the long-term presence of these inflammatory mediators is thought to lead to airway structural changes that are collectively referred to as airway remodeling. Data from our laboratory, and those of others, have suggested a role for IL-13 in the development of mucous cell hyperplasia that is associated with such remodeling. Others also have suggested a role for inflammatory cells such as neutrophils in mediating this process. Using normal human bronchial epithelial (NHBE) cells differentiated in vitro, we have shown recently that IL-13 (10 ng/mL for 24 h) induces the proliferation of NHBE cells via a mechanism that is dependent on the IL-13-induced release of transforming growth factor (TGF)-α by the epithelial cells. This epithelium-derived TGF-α then acts in an autocrine/paracrine manner to bind the epidermal growth factor receptor (EGFR) on these NHBE cells, enhancing proliferation. Specifically, soluble TGF-α is released by NHBE cells in response to IL-13 exposure (1 h), and the immunohistochemical analysis of cells exposed to IL-13 (after 1 and 4 h) has revealed a lack of membrane-bound TGF-α when compared to control cells. The IL-13-induced proliferative response can be blocked in a concentration-dependent manner by AG1478 (0.1, 1, and 5 μg/mL), which is a specific inhibitor of EGFR tyrosine kinase activity, and is eliminated by neutralizing TGF-α antibodies, while control antibodies (ie, anti-platelet-derived growth factor, epidermal growth factor [EGF], and heparin-binding EGF) have no effect.}, number={3}, journal={CHEST}, author={Booth, BW and Newcomb, DC and McKane, SA and Crews, AL and Adler, KB and Bonner, JC and Martin, LD}, year={2003}, month={Mar}, pages={384S–385S} } @article{hashimoto_graham_ho_adler_collins_jones_jarzecka_furlong_peebles_2003, title={Respiratory syncytial virus infection upregulates Muc5ac and gob-5 lung protein expression only in the setting of allergic inflammation.}, volume={167}, journal={American Journal of Respiratory and Critical Care Medicine}, author={Hashimoto, K. and Graham, B. S. and Ho, S. B. and Adler, K. B. and Collins, R. D. and Jones, P. W. and Jarzecka, K. and Furlong, J. and Peebles, R. S., Jr.}, year={2003}, pages={A425} } @article{singh_dick_boykin_andrews_adler_gilmour_2003, title={Role of oxidative stress and p38MAP kinase in murine pulmonary responses to LPS and diesel exhaust particles.}, volume={167}, journal={American Journal of Respiratory and Critical Care Medicine}, author={Singh, P. and Dick, C. A. and Boykin, E. and Andrews, D. and Adler, K. B. and Gilmour, I.}, year={2003}, pages={A622} } @article{pettersen_adler_2002, title={Airways inflammation and COPD - Epithelial-neutrophil interactions}, volume={121}, ISSN={["1931-3543"]}, DOI={10.1378/chest.121.5_suppl.142S}, abstractNote={Neutrophils are recognized as major cellular mediators of inflammation. They contain specific and highly regulated mechanisms for controlling the expression of adhesion molecules that allow for their tethering and migration into inflammatory sites. These adhesion molecules not only are activated by exogenous pollutants but are regulated by endothelial and epithelial cell signals. Lipid mediators, such as platelet-activating factor, reactive oxygen and nitrogen species, and cytokines from airway epithelial cells, further control neutrophil functions such as infiltration and activation resulting in an increase in respiratory burst activity and release of granule enzymes, such as elastase. Furthermore, virus and bacteria products affect inflammation by increasing secondary epithelial mediators. However, once the endogenous or exogenous agents are expelled, neutrophil populations are programmed to die and are cleared by macrophage phagocytosis. Neutrophils are recognized as major cellular mediators of inflammation. They contain specific and highly regulated mechanisms for controlling the expression of adhesion molecules that allow for their tethering and migration into inflammatory sites. These adhesion molecules not only are activated by exogenous pollutants but are regulated by endothelial and epithelial cell signals. Lipid mediators, such as platelet-activating factor, reactive oxygen and nitrogen species, and cytokines from airway epithelial cells, further control neutrophil functions such as infiltration and activation resulting in an increase in respiratory burst activity and release of granule enzymes, such as elastase. Furthermore, virus and bacteria products affect inflammation by increasing secondary epithelial mediators. However, once the endogenous or exogenous agents are expelled, neutrophil populations are programmed to die and are cleared by macrophage phagocytosis.}, number={5}, journal={CHEST}, author={Pettersen, CA and Adler, KB}, year={2002}, month={May}, pages={142S–150S} } @article{singh_daniels_winsett_richards_bishop_dick_madden_adler_gilmour_2002, title={Diesel exhaust particles increase lung injury and inflammation during early sensitization in brown Norway rats.}, volume={66}, number={1-S}, journal={Toxicological Sciences}, author={Singh, P. and Daniels, M. J. and Winsett, D. and Richards, J. and Bishop, L. and Dick, C. A. J. and Madden, M. and Adler, K. B. and Gilmour, M. I.}, year={2002}, pages={147} } @article{singh_winsett_daniels_dick_adler_gilmour_2002, title={Effects of allergic airways disease on influenza virus infection in brown Norway rats.}, volume={165}, journal={American Journal of Respiratory and Critical Care Medicine}, author={Singh, P. and Winsett, D. W. and Daniels, M. J. and Dick, C. A. J. and Adler, K. B. and Gilmour, M. I.}, year={2002}, pages={A183} } @article{booth_adler_martin_2002, title={IL-13 induces intracellular translocation and release of TGF? in human bronchial epithelial cells in vitro.}, volume={165}, journal={American Journal of Respiratory and Critical Care Medicine}, author={Booth, B. W. and Adler, K. B. and Martin, L. D.}, year={2002}, pages={A814} } @article{martin_adler_akley_crews_sharova_2002, title={Secretion-competent mouse tracheal epithelial cell culture from the genetically altered mouse - Pathway analysis via gene array}, volume={121}, DOI={10.1016/S0012-3692(15)35478-7}, abstractNote={The ability to create knockout and transgenic mice with phenotypes mimicking a variety of lung diseases has led to a large body of knowledge detailing the role of various gene products in the development of these diseases. Similarly, the use of well-differentiated human airway epithelial cell cultures has led to an understanding of precise signaling pathways regulating cellular functions such as mucus secretion, adhesion molecule and cytokine expression, and epithelial cell proliferation. The ability to combine these two powerful research approaches lies with creating an in vitro mouse tracheal epithelial (MTE) cell culture system. Here, we report the development of such a primary cell system that maintains morphologic and functional characteristics of the in vivo mouse airway epithelium. Specifically, epithelial cells dissociated from intact mouse tracheas are grown in air/liquid interface culture in defined media with or without serum. Under both conditions, Alcian blue/periodic acid-Schiff–positive mucous cells are observed. In contrast, ciliary development appears to require serum, suggesting that it may be possible to further manipulate this cell culture system to allow precise study of either mucous or ciliated cell development. This cell culture system has been examined to ensure its epithelial nature as indicated by Western blot analyses showing the culture findings to be positive for cytokeratin 5 expression. Using a mouse mucin 5ac-specific antibody to detect secreted protein by enzyme-linked immunosorbent assay, the cultures are found to secrete mucin constitutively and in a stimulated manner in response to known secretagogues (phorbol 12-myristate 13-acetate and 8-Br-cyclic guanosine monophosphate). Although a single trachea yields only 1 cm2 of differentiated culture, our preliminary studies indicate sufficient material can be obtained to perform gene array analyses of control and interleukin-13–exposed MTE cell cultures. Thus, we anticipate use of the MTE cell culture system not only to determine specific signaling pathways important to airway epithelial cell changes during lung disease, but by employing cells from knockout and transgenic mice, we expect to obtain an understanding of how expression of genes controlling these pathways is altered by genetic changes. In this manner, it should be possible to directly interface in vitro experimentation to define precise signaling pathways in airway epithelial cells with in vivo whole animal studies.}, number={3}, journal={Chest}, author={Martin, L. D. and Adler, K. B. and Akley, N. J. and Crews, A. and Sharova, L.}, year={2002}, pages={79S} } @article{adler_li_2001, title={Airway epithelium and mucus - Intracellular signaling pathways for gene expression and secretion}, volume={25}, ISSN={["1044-1549"]}, DOI={10.1165/ajrcmb.25.4.f214}, abstractNote={It is the rare scientific paper dealing with any aspect of airway mucus that does not open with a statement about the contribution of excess mucus to the pathogenesis of airway obstruction, susceptibility to infection, or compromised defense in a myriad of inflammatory airway diseases, such as chronic bronchitis, asthma, bronchiectasis, or cystic fibrosis. Excess mucus in the airways can result from any of three different lesions, and in most cases various combinations of these: ( 1 ) enhanced production through overexpression of mucin (MUC) genes; ( 2 ) excess production secondary to mucus cell hyperplasia, hypertrophy, or even metaplasia; or ( 3 ) hypersecretion of formed and stored mucin by goblet cells or glands in the airways. In context of a perspective, it may be instructive to trace the historical pathways that have led to our present understanding of the mechanisms associated with mucus-related phenomena. Clearly, the importance of studying production and secretion of mucus (or its glycoprotein component, mucin) was not lost on early researchers. In the 1960s and early 1970s, several groups looked at mucus production and secretion in the airways. However, lack of appropriate in vitro or in vivo model systems made these early studies mostly descriptive and limited, for the most part, to characterization of alcian blue/PAS-stained cells in different regions of the airways in health and disease (1-4). In the mid-1970s, with the introduction of organ culture techniques to study isolated rings or explants of bronchi or trachea from several species, it became possible to investigate mechanisms related to production and secretion of mucin (5, 6). Unfortunately, there were serious problems with explant cultures, not the least of which was quantification of produced or released mucin. The “state-of-the-art” at that time was either to measure carbohydrate components of secreted or retained mucin in the explants (such as sialic acid; fucose, or glucosamine [7]) or to incubate the explants with a radiolabeled sugar (such as tritiated glucosamine) for a time period allowing for incorporation of the label into the mucin glycoproteins, and then measure the released radiolabeled activity as a reflection of secreted mucin, or radioactivity within the tissue as a measure of mucin synthesis (8). For greater specificity, the homogenate or spent medium was either precipitated with trichloroacetic acid, sometimes with the addition of phosphotungstic acid, prior to counting of radioactivity. More accurate quantification was achieved by treatment of the homogenate or spent medium with enzymes to digest other contaminating sugar-containing proteins, such as hyaluronic acid or chondroitin sulfate, with hyaluronidase or chondroitinase ABC, respectively. Separation via column chromatography also improved detection, as the high molecular weight mucins would appear in the void volume (9). A second problem related to organ cultures was the large number of cell types present in the explants, confounding interpretation of effects of added agents on epithelium and making it difficult to attribute responses to any particular cell type. There were some major advancements in the field of mucin research during the 1980s, both in the development of better cell culture techniques and in detection of intraand extracellular (secreted) mucin. The first was a great improvement in our ability to culture cells from airway epithelium from several species. Prior to this time, it was difficult to culture airway epithelial cells so as to maintain differentiated characteristics in vitro , but the development of defined, serum-free medium, as well as improvements in the types of substrata beneath the cultured cells, gave researchers the ability to culture airway epithelial cells that looked and acted somewhat like their in vivo counterparts. Maintaining cells in a defined medium atop a collagen gel provided improved model systems, and in the latter part of the 1980s, the concept of air/liquid interface culture was first introduced. Starting with guinea pig tracheal epithelial cells (10, 11), it was discovered that cells grown on a collagen substrate, atop a permeant filter, with all medium placed beneath the cells and only a humidified air environment above, would result in well-differentiated epithelial cells essentially identical in structure and function to airway epithelium in situ . In quick succession, techniques for air/liquid interface culture of airway epithelium from rat (12), bovine (13), canine (14), primate (15), and eventually human (16-18) cells were developed. At present, culturing human airway epithelial cells in air/liquid interface provides a model system in which the epithelial cells are similar if not identical to human airway epithelium in vivo , and such cells now can be purchased commercially. With regard to detection of intracellular or secreted ( Received in original form September 10, 2001 )}, number={4}, journal={AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY}, author={Adler, KB and Li, YH}, year={2001}, month={Oct}, pages={397–400} } @article{booth_bonner_adler_martin_2001, title={Autocrine production of TGFa mediates interleukin 13-induced proliferation of human airway epithelial cells during development of a mucous phenotype in vitro.}, volume={163}, journal={American Journal of Respiratory and Critical Care Medicine}, author={Booth, B. and Bonner, J. C. and Adler, K. B. and Martin, L. D.}, year={2001}, pages={A738} } @article{macchione_akley_adler_martin_2001, title={Differentiation of murine tracheal epithelial cells in vitro.}, volume={163}, journal={American Journal of Respiratory and Critical Care Medicine}, author={Macchione, M. and Akley, N. J. and Adler, K. B. and Martin, L. D.}, year={2001}, pages={A225} } @article{li_martin_minnicozzi_greenfeder_fine_pettersen_chorley_adler_2001, title={Enhanced expression of mucin genes in a guinea pig model of allergic asthma}, volume={25}, ISSN={["1535-4989"]}, DOI={10.1165/ajrcmb.25.5.4485}, abstractNote={Section:ChooseTop of pageAbstract <in vitro. Down-regulation of MARCKS expression or disruption of MARCKS function in these cells inhibits the secretory response to subsequent stimulation. The intracellular mechanism controlling this secretory process involves cooperative action of two separate protein kinases, protein kinase C and cGMP-dependent protein kinase. Upon stimulation, activated protein kinase C phosphorylates MARCKS, causing translocation of MARCKS from the plasma membrane to the cytoplasm, where it is then dephosphorylated by a protein phosphatase 2A that is activated by cGMP-dependent protein kinase, and associates with both actin and myosin. Dephosphorylated cytoplasmic MARCKS would also be free to interact with mucin granule membranes and thus could link granules to the contractile cytoskeleton, mediating their movement to the cell periphery and subsequent exocytosis. These findings suggest several novel intracellular targets for pharmacological intervention in disorders involving aberrant secretion of respiratory mucin and may relate to other lesions involving exocytosis of membrane-bound granules in various cells and tissues.}, number={44}, journal={JOURNAL OF BIOLOGICAL CHEMISTRY}, author={Li, YH and Martin, LD and Spizz, G and Adler, KB}, year={2001}, month={Nov}, pages={40982–40990} } @inbook{li_martin_adler_2001, title={MARCKS protein: a potential modulator of airway mucin secretion.}, booktitle={Cilia and mucus: from development to respiratory disease.}, author={Li, Y. and Martin, L. D. and Adler, K. B.}, year={2001}, pages={179–193} } @article{bonner_wang_zhang_rice_zhang_adler_choe_kagan_2001, title={Role of receptor tyrosine kinases and mitogen-activated protein kinases in metal-induced pulmonary fibrosis}, volume={120}, ISSN={["0012-3692"]}, DOI={10.1378/chest.120.1_suppl.S55}, abstractNote={The proliferation of lung fibroblasts is a key component of pulmonary fibrosis. Several cell-surface receptor tyrosine kinases, including the platelet-derived growth factor receptor (PDGF-R) and epidermal growth factor receptor (EGF-R), mediate fibroblast mitogenesis via the activation of mitogen-activated protein (MAP) kinases. We have developed a model of metal-induced oxidative stress in rats using vanadium pentoxide (V2O5) that is characterized by interstitial and peribronchiolar fibrosis, airway smooth-muscle thickening, and mucous cell metaplasia. In vivo activation of the extracellular signal-regulated kinases (ERKs [ERK-1 and ERK-2]) was demonstrated by immunohistochemistry in fibrotic lesions caused by V2O5 exposure. Moreover, V2O5 injury upregulated platelet-derived growth factor α-receptor messenger RNA (mRNA) and protein in vivo. The mechanism of PDGF-Rα upregulation by V2O5 was elucidated in vitro and involved the release of interleukin-1β by alveolar macrophages, which then activated lung fibroblasts in a paracrine manner to activate p38 MAP kinase, which caused stabilization of PDGF-Rα mRNA. V2O5 also activated ERK-1 and ERK-2 in cultured lung fibroblasts in an oxidant-dependent manner that involved upstream activation of the EGF-R, Raf-1, MAP kinase kinase signaling cascade. In another study, V2O5 exposure of human bronchial epithelial cells in vitro caused the release of mitogenic activity for human lung fibroblasts that was abolished by a neutralizing antibody against heparin-binding epidermal growth factor-like growth factor. Induction of heparin-binding epidermal growth factor-like growth factor mRNA and protein by V2O5in vitro was reduced by the MAP kinase kinase inhibitor PD98059 and the p38 MAP kinase inhibitor SB203580. Finally, the intraperitoneal administration of tyrosine kinase inhibitors specific for either the PDGF-R or the EGF-R (tyrphostins AG1296 and AG1478, respectively) significantly reduced pulmonary fibrosis in rats exposed to V2O5. Collectively, these studies have identified signaling pathways and inducible genes activated by V2O5-stimulated oxidative stress that may offer potential targets for therapeutic intervention of pulmonary fibrosis.}, number={1}, journal={CHEST}, author={Bonner, JC and Wang, YZ and Zhang, P and Rice, A and Zhang, LM and Adler, K and Choe, N and Kagan, E}, year={2001}, month={Jul}, pages={55S–56S} } @article{zhang_rice_adler_sannes_martin_gladwell_koo_gray_bonner_2001, title={Vanadium stimulates human bronchial epithelial cells to produce heparin-binding epidermal growth factor-like growth factor - A mitogen for lung fibroblasts}, volume={24}, ISSN={["1044-1549"]}, DOI={10.1165/ajrcmb.24.2.4096}, abstractNote={Section:ChooseTop of pageAbstract <